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INTRODUCTION 
 
Ascites refers to excessive pathologic accumulation of fluid in 
Peritoneal cavity
27
. The most common cause of ascites is CIRRHOSIS 
WITH PORTAL HYPERTENSION (85%)
 14which
 occurs in 50% within 
10 years of diagnosing cirrhosis
40
 
 
The development of ascites denotes the patient progresses to 
decompensated cirrhosis.Other complications are variceal hemorrhage, 
hepatic encephalopathy or jaundice; ascites is the most common
54
.. 
 
It is due to factors involving the peritoneum (malignancy), 
infection,or diseases away from the peritoneum , heart failure, 
hypoproteinaemia,liver disease). 
 
Cirrhosis most important causative agent of ascites in the West 
(76%),peritoneal malignancy (14%), cardiac failure (5%) and peritoneal 
tuberculosis(4%). 
 
Cirrhosis is a linguistic disorder with indolent course and many 
patients will be asymptomatic until decompensation. Early and well-
compensated cirrhosis usually present as loss of apetite and weight loss, 
malaise, fatigue and weakness
28
. 
 
Decompensated Liver Disease is an end stage liver disorder  with 
liver fibrosis and with complications like ascites, variceal 
bleeding,hepatic encephalopathy,enzymes production and reduced 
metabolism,hepatopulmonary syndrome 
54
.  
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DCLD patients have a poor prognosis and their 1-year and 5-year 
survival rates of 80% and 56% respectively
40
. 
 
Cirrhosis is an immunosuppressed  status where both cell 
mediated and humoral immunity are decreased 
21,54
.These patients have 
reduced  serum bactericidal opsonins, complements(C3,C4), protein C 
and fibronectin 
39
. There is local and systemic immune dysfunction. 
Owing to porto-systemic shunting bacteria and bacterial endotoxins are 
not cleared by liver from portal circulation
21
. This predisposes patients 
to lot of infections 
21
. This is later  complicated by alcohol consumption, 
malnutrition, invasive procedures, catheters, immunomodulatory
21
. 
 
DCLD is associated with increased susceptibility to infections
22
. 
Bacterial infections takes  for 37%-57% of deaths in these patients
21
. 
  
Nosocomial infections have an rate of 30%-32% and may be upto 
49% with variceal bleeding
21
.The most common bacterial infections 
inthe descending order of frequency are Spontaneous bacterial 
peritonitis (SBP) (15-30%),Urinary tract infections (25-29%), 
pneumonia (18-22%),bacteremia (17%) and soft tissue infection (15%). 
 
Gastrointestinal variceal hemorrhage is accompanied with 
infection in60% of cirrhotics due to disruption of intestinal mucosal 
barrier andinvasive procedures during bleeding. 
 
3 
 
Infection triggers cytokine pathway  with release of vasoactive 
mediators which causes increased variceal pressure, disordered 
homeostasis leading to furthervariceal bleeding. 
 
Infections are  most common if  there is failure to control 
gastrointestinal bleeding within 120 hours and associated with 
earlyrebleeding rate .Antibiotic prophylaxis prevented infection and 
episodes ofrebleeding and also the need for blood transfusion
70
. 
 
The prevalence of this condition in those hospitalized with 
DCLD is 10-37% with 28% of  those with hepatic encephalopathy
44
. 
The recurrencerate after first SBP episode is 41% at 5months,63% at  
1year and 72% at two years
37
 and sensible prophylaxis can reduce the 
recurrence rate to25%
3
. The frequency of ascitic fluid infection among 
outpatients is as lowas 0-3.7%
69
.The in-patient mortality varies from 22-
45%, with mortality rate of 57-72% at one year of follow up
44
.  
 
Serumcreatinine levels >1.5 mg/dl with lab culture were 
goodpredictors of mortality
44
.The progress of underlying liver disease 
isdifficult to control and hence early detection and timely 
precisemanagement of infections can improve the outcome
70
. 
 
AFIs are under diagnosed by conventional culture methods since 
the median bacterial concentration is only approximately 1-
2organismper milliliter
15
. 
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Hence, this study was done to detect Ascitic Fluid Infections 
(AFIs) in outpatients & inpatients with Decompensated Liver Disease 
(DCLD), by bedside inoculation of ascitic fluid in leucocyte esterase 
ascitic fluid strip test. This could increase diagnosting infection at earlier 
time, facilitate rapid isolation of organisms and help to administer 
appropriate antimicrobialtherapy at the earliest. 
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AIMS & OBJECTIVES 
 
1.The usefulness of  leukocyte esterase ascitic fluid strip analysis 
in the rapid and early diagnosis of spontaneous bacterial peritonitis on 
decompensated chronic liver disease patients with ascites, so that rapid 
diagnosis of ascitic fluid infection and starting early treatment to reduce 
the morbidity and mortality of the disease which can be established. 
 
2.The Objective is to find out the leukocyte esterase ascitic fluid 
strip analysis  accuracy in the spontaneous bacterial peritonitis and after 
successful treatment with iv antibiotics the efficacy of the strip test in 
spontaneous bacterial peritonitis. 
 
3.To study  the Incidence and Prevalence of Ascitic Fluid 
Infections (AFIs) in Cirrhotic patients of various  etiologies. 
 
 
4. To Allegorize the prevalence of Ascitic Fluid Infections (AFIs) 
inoutpatients & inpatients with Cirrhosis. 
 
5. To Establish  whether bedside strip tests and bed side 
inoculation of ascitic fluid into bloodculture bottles combined with 
newer culture detection methods employing non-ionic surfactants 
(Triton-X 100 and Tween 80) helps in the identification of ascitic fluid 
infection. 
 
6. To study the microbial spectrum of Ascitic Fluid Infections 
(AFIs) from outpatients & inpatients with DCLD. 
6 
 
REVIEW OF LITERATURE 
 
Cirrhosis means a non remitting progressive, diffuse, fibrotic and 
nodular regeneration of liver so that the liver architecture is disrupted
61
. 
 
Long standing injury to the liver can proceed on to insult the liver 
to cause cirrhosis. There is persistent wound healing resulting in 
fibrosis.80-90% of the liver parenchyma must be destroyed for liver 
dysfunction to exhibit clinically
38
.Cirrhosis is a indolent disease with 
silent course and many patients remain symptom free until they 
reachdecompensation.  
 
Alcoholic liver disease(ALD) is an important risk factor for 
cirrhosis
38
. Individuals who consume large amounts of alcohol for 
prolongedperiod (about >64-84grams/day in males and>22grams/day in 
females over 11 years or longer) progress beyond the stage of steatosis 
of liver (92%) to develop alcoholic hepatitis and fibrosis (12-37%) then 
to cirrhosis (5-18%)
61.
 
 
Women are more prone to develop Alcoholic liver disease within 
shorter life span due to increased activity of alcohol dehydrogenase 
activity in the gastric mucosa and liver and they have a lean body mass 
different from men and lower threshold toxic dose. This has been 
attributed to the gender 
dependent differences in the hepatic metabolism of alcohol
61
. 
 
The complications of liver disease are due to impaired hepatic 
function and disruption of the normal hepatic architecture
61
. 
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FLUID RETENTION IN CIRRHOSIS
40
 
 
Ascites is a greek term (askes) which refers to a bag/sac
22
.In 
cirrhotic patients there is more formation of vasoconstrictorswhich leads 
to increasedvascular tone. There is distortion of architecture of the liver. 
Both theselead to PORTAL (SINUSOIDAL) HYPERTENSION.This 
portal hypertension activates vasodilatory mechanisms. There is 
increased production of nitric oxide (NO) which leads to splanchnicand 
peripheral arterial vasodilation.This later causes decreased levelling of 
systemic vasculature and drop in pressure.This causes baroreceptor-
inducedactivation of renin pathway with increased activity of 
sympathetic drive and arginine vasopressin .These events lead to renal 
sodium and water retention torestore normal 
homeostasis.Also,splanchnic vasodilation leads to increased lymph 
production and leakage into peritoneal cavity.Both the events lead to 
sustained ascites formation
40
. 
 
CLASSIFICATION OF ASCITES-THE INTERNATIONAL 
ASCITES CLUB
40
 
 
Grade one Ultrasound detected. 
 
Grade two Abdominal distension. 
 
Grade three Tense Ascites 
 
Ascites (Uncomplicated)Infection/HRS absent. 
 
8 
 
Refractory ascites prevention with drug treatment after therapeutic 
paracentesis. 
 
Diuretic-resistant ascites  high dose /maximum dose of diuretic 
treatment. 
 
Diuretic-intractable ascitesdiureticscausing side effects leading to 
improper treatment. 
 
DIFFERENTIAL DIAGNOSIS OF ASCITES
14
 
Cirrhosis-85% 
OTHERS-15% 
Alcoholic hepatitis 
Cancer (peritoneal carcinomatosis, massive liver metastases, etc) 
“Mixed” ascites, i. e., cirrhosis plus another cause for ascites 
Pancreatitis 
Nephrotic syndrome 
Tuberculous peritonitis 
Heart failure 
Acute liver failure 
Budd-Chiari syndrome 
Postoperative lymphatic leak 
Sinusoidal obstruction syndrome 
Myxedema. 
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HISTORY 
 
It is of historical interest that Ludwig von Beethoven is probably 
the first patient known by name to have had SBP, especially since the 
clinical description of his case had been written 135 years before this 
syndrome was first described.Kerr et al & Conn, printed papers which 
explained ascitic fluid infections (AFIs) in the absence of contiguous or 
intra-abdominal source of infection
10
.  
 
In 1964, CONN was the one coined the term Spontaneous 
bacterial peritonitis (SBP)
3
. Runyon who has done several works in SBP 
suggests we now drop the term “SPONTANEOUS” since the 
pathogenesis has been studied and worked out
25
. 
 
PATHOGENESIS 
GENERAL CONCEPT 
 
In cirrhosis bacterial overgrowth leads to the migration from the 
intestinal lumen into mesenteric nodes and into the  systemic circulation 
and other extra-intestinal sites since they pass through the liver and 
increased majority of portal flow diverts away from the liver 
sinusoids
41,42,21
.This persistent bacteremia leads to ascitic fluid infection 
since it is an excellent bacterial culture medium
41,3.
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BACTERIAL OVERGROWTH 
 
WHAT ARE THE POSSIBLE ROUTES BY WHICH BACTERIA 
MAY ENTER THE PERITONEUM? 
 
Organisms can come directly from the gastrointestinal tract, from 
the blood stream.The rarest route is through the Fallopian tubes.This 
route of entry has been implicated by McCartney to explain the 
predominance of girls with primary peritonitis 
(5). 
 
The most common causes of bacterial peritonitis were 
perforations of ulcers of the upper gastrointestinal tract or the rupture of 
abdominal viscera, usually the appendix. Although perforations of the 
gastrointestinal tract may be silent clinically, they are rarely so, and 
even when silent they usually exhibit pneumoperitoneum.Under certain 
conditions bacteria may enter the peritoneal cavity by traversing the 
intact intestinal wall
66
.  
 
Bacterial overgrowth occurs from the overgrowth of a single 
species of indigenous bacteria in the intestinal tract, 
immunosuppression, and thermal injury in which large segments of skin 
are burned, to hemorrhagic, hypotensive shock, i.e., insufficient blood 
supply to the gastrointestinal (GI)  tract. In addition, specific disorders 
of the GI tract, such as intestinal or biliary obstruction or portal 
hypertension, may all give rise to Bacterial overgrowth
31
.  
 
It is possible that the hepatic lymphatics themselves may be 
involved in the pathogenesis of this syndrome. Hepatic lymph is 
11 
 
the key to the formation of ascites. In cirrhotic patients with 
hepatic venous outflow obstruction the production of hepatic lymph is 
increased resulting in the formation of ascites, due largely to the 
exudation of hepatic lymph directly into the peritoneal cavity
31
. 
 
II. WHAT ARE THE FACTORS THAT RENDER CIRRHOTIC 
PATIENTS PARTICULARLY PRONE TO DEVELOP 
SPONTANEOUS PERITONITIS? 
 
Failure of hepatic removal of bacteria from the blood stream. 
McIndoe described the extrahepatic portal-systemic collateral networks 
that shunt portal venous blood around the liver. 
 
Such portal-systemic shunts have been shown to diminish greatly 
thehepatic clearance of ammonia and other substances absorbed from 
the gastrointestinal tract.Presumably, these portal-systemic anastomoses 
permit circulating bacteria to bypass the hepatic reticuloendothelial 
filtering system, which has been shown to be the major site of removal 
of bacteria from the blood.  Decreased hepatic removal of circulating 
bacteria tends to perpetuate bacteremia and thus afford circulating 
organisms a greater opportunity to cause metastatic infections at 
susceptible sites such as ascitic collections
41,42
.  
 
Normally the portal venous blood is aseptic. In case of migration 
of bacteria from infected lumen , they are getting trapped and removed 
by the liver. Cirrhotics have increased and abnormal bowel flora
41
. 
Bacterial overgrowth is increased in cirrhosis by delayed intestinal 
transit, decreased luminal IgA and bile salts
66
. 
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Normal distal movements of luminal contents by peristalsis helps to 
avoid bacterial colonization and multiplication  in the upper intestine. 
The complete or partial absence of the phase III activity of 
MMC(MIGRATORY MOTOR COMPLEX)-the “intestinal 
housekeeper” results in overgrowth17. In cirrhosis, there is increase in 
bacterial colonization of the small bowel (31-53%) with bacteria from 
the large bowel
38
. 
 
INTESTINAL MUCOSAL BARRIER 
SECRETORY (1
st
 DEFENCE) MECHANISM 
 
The intestinal goblet epithelial cells secrets mucins thatelectro-
negative charged layer prevent direct contact between bacteria and 
intestinal membrane. In cirrhotics there is elevated permeability of 
mucosa (patients withsepsis) due to oxidative stress, elevated Nitric 
Oxide and, endotoxemia, proinflammatory cytokine,enterocyte 
mitochondria malfunction 
38
. 
 
 
IMMUNOGLOBULIN A 
 
70% of body’simmunoglobulin production is IgA.Incirrhotics 
there is diminished mucosal IgA
17,38.12.
 
 
BILE’s TROPHIC EFFECT  
 
Bile inhibits intestinal bacterial overgrowth; bile has detergent 
action and anti-adherence properties, endotoxin removal, trophic effect 
13 
 
for intestinal mucosa with decreased epithelial bacteria internalisation. 
The quantity of bile acids in liver disease is diminished due to decreased 
secretion and accentuated deconjugation of intestinal flora. It aids 
bacterial translocation caudes by endotoxins
17,38. 
 
THE PHYSICAL(2
nd
 line of  DEFENCE) MECHANISM 
 
INTESTINAL EPITHELIAL STRUCTURE   
 
Tight junctions between the cells  located at  the apicolateral  
surface of the epithelium inhibits bacterial or liopolysacchride transport. 
In liver disease  there is intercellular spaces widening, diminished crypts 
and villus,Vasodilation,muscularis mucosae involovement,Oedema,and 
fibromuscular proliferation all dislodge the integrity of the normal 
epithelium
38
. 
 
NATURAL ANTIBIOTICS SECRETION 
 
Paneth cells in the  jejunal crypts and ileal crypts produce -
phospholipase A2. defensins, and lysozyme,cryptidin related signal 
peptides,Angiogenin 
4
. 
 
Small intestine epithelial cells and Colonic epithelial cells secrete 
– defensins that defend against commensal bacteria. In chronic liver 
disease  secretion of these substances with antimicrobial activity is 
reduced
.13 
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GUT ASSOCIATED LYMPHOID TISSUE. 
 
Four components 
Lymphocytes from the lamina propria. 
Intraepithelial lymphocytes 
Mesentric lymph nodes(MLN) 
Peyer’s patches 
 
 
When the Bacteria interact with the structures in the Gut 
associated Tlymphocytes there is multiplication of lymphocytes, 
germinal center appearin the follicles and mucosal immunoglobulin 
secretion elevated 
38
. 
 
The primary immune response was associated with monocytes, 
By its  interaction of with PRR-PATTERN RECOGNITION RECEPTOR 
with specific bacterial ligands PAMPs- PATHOGEN ASSOCIATED 
MOLECULAR PATTERNS. Antigens are taken  up by the dendritic cells 
through the local antigenpresenting cells (APCs)-DIRECT 
MECHANISM and by M cells whichovertake antigen by endocytosis-IN 
DIRECT MECHANISM 
38
. 
 
Microbial peptides are presented by the Antigen presenting cells  
to the B & T lymphocytes. This will reach a climax in secretion of 
mucosal IgA(or IgG) or transformation into Th1 and Th2 cells. On 
exposure to the antigen, the T lymphocyte from the Peyer’s 
patches
14
move towards lamina propria and getstranformed into CD8 
15 
 
cytotoxic T lymphocytes. Impaired primary and adaptive immune 
response occurs in DCLD
38,17. 
 
BACTERIAL TRANSLOCATION 
 
Portal hypertension causes venous stasis, hypoxia of the mucosa 
and oxidative stress damage
28,30
. This leads to splanchnic dilatation with 
Mucosal congestion and Bowel Oedema leading to alteredpermeability 
and bacterial translocation to mesentric lymph nodes
40
. Gram negative 
bacteria are more adapt than grampositives and anaerobes in 
translocation
66
.Bacteria generally do not migrate directly fromthe lumen 
into ascitic fluid. It happens if there is loss ofmucosal integrity. 
Anaerobes are present in excess in gut flora which translocate only in 
intestinal mechanical injury and are occasionally isolated from ascitic 
fluid in SBP
66,17
. More virulent organisms and Escherichia coli strains 
with greater adherence to intestinal mucosa translocate more precisely 
21.
 
 
INVASION OF ASCITIC FLUID AND BACTEREMIA  
 
Splanchnic and systemic vascular dilatation with the formation of 
hyperdynamic circulatory state with elevated cardiac output and drop in 
blood pressure
21
. Bacteremia leads to spill over of the organisms from 
mesenteric lymph nodes into systemic circulation.
15 
 
Due to  the diminished phagocytosis of reticuloendothelial 
system, the bacteria stays uncleared from the circulation
66
. In cirrhotics 
with  intra and extra hepatic shunts the bacteria never  come into 
alignment with the Kupffer cells and the bacteremia 
16 
 
increases
17
.Bacteremia  leads to colonisation of ascitic fluid as the 
infected fluid oozes off of the Glisson’s capsule or when infected 
interstitial fluid oozes from the intestinal capillary bed. 
 
SBP AND BACTERASCITES  
 
Opsonins level and C3 complement are decreased in DCLD. Low 
protein concentration (<1g/dl) with positive correlation and decreased 
opsonic activity.Opsonins and macrophage were not able to kill the 
bacteria and so neutrophils are allowed to do the killing. SBP occurs, 
since there is impaired neutrophil function or qualitative neutrophil 
abnormalities.
40,58,66,17. 
 
SEPSISANDSYSTEMIC INFLAMMATORY RESPONSE 
SYNDROME  
Molecular evidence of bacterial translocation is given by 
Identifying the DNA of the bacteria in the body fluid
47
. 
Lipopolysaccharides and peptidoglycans in the bacteria can trigger the 
TLR receptors
16
that leads to the production of pro-inflammatory 
cytokines. This leads to  increased release of Tumor Cytokines that leads 
to inadequate tissue perfusion, multi- organfailure and death, refractory 
hypotension,sepsis syndrome pathways 
21,42,58.
 
 
ASCITIC FLUID INFECTIONS(AFI). 
Most frequent (31%) of all infections among cirrhosis with portal 
hypertension
25
. Ascitic fluid infections(AFIs) has been classified into 
five variants based on analysis of the following parameters- 
17 
 
Polymorphonuclear leukocyte (PMN) count, culture growth and mode 
of entry of organism into the fluid
66
. 
 
ASCITIC FLUID INFECTIONS VARIANTS  
VARIANTSOFASCITIC FLUID 
INFECTIONS(AFIs) 
PMNCOUNT 
Cells/mm
3 
CULTURE 
GROWTH 
Spontaneous bacterialperitonitis(SBP) •250 Monomicrobial 
Culture-negative neutrocyticascites 
(CNNA) 
 
•250 
 
Nogrowth 
Monomicrobial nonneutrocytic bacterascites 
(MNB) 
 
<25
0 
 
Monomicrobial 
Secondary bacterial peritonitis-Indicates 
surgical cause such as perforated 
viscus/intra-abdominal abscess. 
 
 
•250 
 
 
Polymicrobial 
Polymicrobialbacterascites-Perforation of the 
bowel by paracentesis needle. 
 
<25
0 
 
Polymicrobial 
 
In symptomatic SBP caused by GPC, the PMN count 
is<250/mm
3(40) 
. SBP and CNNA variants of same disease and SBP was  
severe variant with greater mortality than CNNA
44. 17
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HEPATORENAL SYNDROME
4
 
 
The annual incidence of HRS in patients with ascites is 
10%.There is no major change in renal biopsy and is completely 
relieved by liver transplantation. 
New Diagnostic criteria of the hepatorenal syndrome
12
. 
 
 Cirrhosis with ascites 
 Serum creatinine >1.5 mg/dL (133μmol/L) 
 No improvement of serum creatinine (decrease to a level of 
1.5 mg/dL or less) after at least 2 days of diuretic withdrawal and 
volume expansion with albumin.  
 The recommended dose of albumin is 1 g/kg of body weight per 
day up to a maximum of 100 g/day 
 Absence of shock 
 No current or recent treatment with nephrotoxic drugs 
 Absence of parenchymal kidney disease as indicated by 
proteinuria of >500 mg/day, microhematuria (>50 red blood 
cells per high power field), and/or abnormal renal 
ultrasonography 
Adapted from Salerno et al. 
[12].
 
 
HRS TYPE 1 
 
Renal failure with increased serum creatinine reaching more than 
2.5 mg/dl
(12)
 in <2 weeks. May occur spontaneously or in can be 
precipitated by bacterial infections, gastrointestinalhaemorrhage or acute 
hepatitis superimposed on cirrhosis. Develops in 30% of inpatients with 
SBP
32
. 
19 
 
HRS TYPE 2 
Moderate and steady decrease in renal function over months 
(serum creatinine < 2.5 mg/dl). There is severe ascites with poor or no 
response to diuretics (refractory ascites).  
 
CHILD TURCOTTE PUGH (CTP) SCORE
61 
 
Initially used to prognosticate the short term mortality,it is now 
used to assess the prognosis and the requirement for liver 
transplantation. It contains parameterslike ascites and hepatic 
encephalopathy. 
 
S.NO VARIABLE 1POINT 2POINTS 3POINTS 
1. Totalbilirubin <2mg/dl 2-3mg/dl >3mg/dl 
2. Albumin >3.5g/dl 2.8-3.5g/dl <2.8g/dl 
3. INR <1.7 1.7-2.2 >2.2 
4. Ascites No Mild (Medically 
controlled) 
Severe 
(Poorly 
controlled) 
5. Hepatic 
Encephalopathy 
No GradeI-II (Medically 
controlled) 
GradeIII-IV 
(Poorly 
controlled) 
 
 
A : 5-6 points.B : 7-9 points. C : 10-15 points. 
 
MODEL FOR END- STAGE LIVER DISEASE (MELD) SCORE
50
 
 
20 
 
Includes three lab objectives international normalized 
ratio(INR),serum creatinine and serumbilirubin. MELD=9.57×loge 
(creatinine)+3.78×log e(total bilirubin) +11.2×loge(INR) + 6.43. 
 
MELD is better than CTP in evaluating the mortality following 
variceal bleeding. Addition of  the creatinine which measures the  renal 
function, explaining its importance in evaluation of mortality risk.CTP 
has  more variability than MELD. Also MELD has wider possible scores 
and offers more weightage than CTP. Patients with high MELD 
score(>5) are more prone for infections and mortality than patients with 
low MELD score(<15). 
 
PREDISPOSING AGENTS FOR ASCITIC FLUID 
CONTAMINATION IN DCLD
37
 
 
 Severity of the liver disease-Child-Pugh class C patients 
 Urinary tract infection and asymptomatic bacteruria14 
 Serum total bilirubin level MORE THAN 2.5 mg/dl 
 Gastrointestinal bleeding 
 Low platelet count(<80,000/mm3) 
 Increased prothrombin time54 
 Increased liver enzymes54 
 Previous episodes of SBP21 
 Ascitic fluid protein level <1g/dl and complement C3 <13 mg/dl 
  High creatinine and blood urea nitrogen 
 
 
 
21 
 
SIGNS AND SYMPTOMS 
 
The most common reported are: 
 Fever(68%) 
 Abdominal pain(68%) 
 Hepatic encephalopathy(53%) 
 Ileus or Diarrhea(31%) 
 Vomiting(20%) 
 About 14% of patients with SBP are asymptomatic37,63. 
 
RECOMMENDATIONS FOR DIAGNOSIS OF AFIs. 
 
The AFIs  clinically presents  with single or multiple symptoms. 
Considerable elapse of time leads to raised morbidity and mortality. The 
diagnosis is primarily on ascitic fluid analysis
5,40,3.
 
 
Attempting to correct coagulopathy is not needed and is not cost 
Evading
3
. 
 
DIAGNOSTIC PARACENTESIS
3,5,37
 
 
 New onset ascites 
 Localising signs of peritonitis mentioned above22 
 At the time of each admission to hospital 
 In gastrointestinal bleeding prior to antibiotic prophylaxis. 
 Any other laboratory test abnormalities  
 Rapid impairement renal function 
 Paracentesis is safe despite the predictable coagulopathy in  
cirrhotic patients. 
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 The risk of complication is  negligible-prolonged leakage(m/c) 
2% chance of abdominal wall haematoma, 0.02% chance of 
haemoperitoneum and 0.02% chance of iatrogenic infections (0.7%), 
visceral perforation. This clearly outways the benefits.
3,8,66.
 
 
ASCITIC FLUID LABORATORY TESTS DATA
14
 
 
ROUTINE OPTIONAL UNUSUAL UNHELPFUL 
Cellcount and 
differential 
Culture in blood 
culture bottles 
AFBsmear 
&culture 
 
PH 
Totalprotein Gram’sstain Cytology Lactate 
Albumin Glucose Triglyceride Fibonectin 
 Amylase Bilirubin Cholesterol 
 Lactate 
dehydrogenase 
  
Glycosaminoglycans 
 
TESTS TO BE DONE FOR DIAGNOSIS OF AFIs
66
 
Cell counts with differential 
Culture (in blood culture bottles) 
Gram’s stain23 
Total protein 
Lactate dehydrogenase 
Glucose 
Amylase 
Albumin (to calculate SAAG) 
SAAG = Serum-ascites albumin gradient. 
These tests also help to readily differentiate and identify the 
various etiologies of ascites besides from portal hypertension.  
23 
 
The SAAG (Serum-ascites albumin gradient) helps in delineating ascites 
better than the total protein based (transudate/exudates) criteria
14
. 
 
CORRECTED SAAG 
 
In serum hyperglobulinemia (>5g/dl), narrow SAAG gradient 
occurs in 1% of ascitic fluid specimen. 
 
CORRECTED SAAG = Uncorrected SAAG × 0.16 × (serum globulin 
[g/dl] + 2.5) 
 
MIXED ASCITES
61
 
 
Have underlying portal hypertension with cirrhosis along with 
other conditions like TB or peritoneal carcinomatosis.  SAAG was more, 
due to underlying portal hypertension.
24 
 
MACROSCOPY: GROSS APPEARANCE61 
 Crystal clear- protein level decreased 
 Transparent and yellow-Non-neutrocytic ascites 
(PMN<250/mm3) 
 Cloudy-Cells value of 5000/mm3 is cloudy,and greater than 
50,000/mm3 appears mayonnaise. 
 Bloody- Ascitic Fluid red blood of Ten thousand/mm3 is the   
maximum value.RBC more than 20,000/mm3 is always red.Seen 
in 50% of cases with cirrhosis and hepatocellular carcinoma. 
 Chylous/Milky-AsciticFluidwith triglyceride content>200 mg/dl. 
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 Found in malignancy-related ascites and in about 21% of 
cirrhotic ascites. 
 Dark brown-Biliary concentration more than that of serum, due to 
biliary perforation. 
 
IMPORTANCE OF  CELL COUNT 
 
The ascitic fluid POLYMORHONUCLEAR LEUKOCYTES 
count (maximum> two fifty cells/mm3) is the efficient test for diagnosis 
of AFI.But PMN count above this value can also be found in bleeding 
into ascites,peritoneal carcinomatosis and pancreatic ascites 
66
.  
 
In tuberculous or malignant ascites, lymphocytesincrease. 
 
HAEMORRHAGIC ASCITES =CORRECTION FACTOR 
5
 
 
Accurate PMN count can be calculated only in non-traumatic tap. 
 
Haemorrhagic fluid can occur in severe coagulopathy or in 
bloody tap, malignant ascites
5
. 
 
MANUAL VS AUTOMATED COUNTING 
 
The laboratory should perform the cell count within 60 minutes. 
The manual count is error-prone and subjective and  it also retards the 
start of ever needed empirical antibiotic therapy
3,13,69.
 
 
Automated cell counters are ideal but the manufacturers do not 
recommend it for fluids other than blood
13
. 
25 
 
This can be useful if further  validated
14
. 
 
ASCITIC LEUKOCYTE ESTERASE REAGENT (LERS) 
STRIPS/ASCITIC FLUID NITRITE REAGENT STRIP DIPSTICS 
 
Leukocyte esterase is an intracellular enzyme within the PMNs 
and is released upon lysis of PMNs during inflammatory cascade
20
.The 
strip is placed inside a test tube of fresh ascitic fluid at the bedside and 
kept for 90 seconds.  
 
The esterase present in the PMNs act on the ester substrate and 
releases 3-hydroxy-5-phenyl-pyrrole.this changes the color of an azodye 
in the reagent strip. The calorimetric scale reference chart is availablefor 
direct optical comparison on the sides of the container
3
. 
 
See for  the purple colour on the strips which is equivalent to a 
PMN count of 250/mm3 so that first dose of empiric antibiotic can be 
given (reduces the tap-to-shot time). It isfaster and cheaper rapid. The 
sensitivity is  95%, specificity 88% and negative predictive value of 
95%
13,69
. Example: NEPHUR TEST AND MULTISTIXSG10.However, 
study conducted on a large scale showed only 45% sensitivity
14
. 
 
SECONDARY PERITONITIS
40,5,20,54 
Look for it when:
 
1. No diminish in ascitic fluid PMN count 48 hours after antibiotic
 
starting. 
2. Two or more organisms shown on culture (espfungusor anaerobes). 
3.If in ascitic fluid atleast two (2/3) is seen: 
26 
 
-- AF protein >1g/dl. 
-- AF lactate dehydogenase(LDH)>225mU/ml(normal serumlevel). 
-- AF glucose <50 mg/dl. 
Antibiotics against anaerobes and enterococci have to be added. 
RELAVENT ADDITIONAL INVESTIGATIONS
3,5
 
1. Blood cultures associated with the ascitic fluid cultures-positive 
in atleast 1/3 rd of cases
26
. 
2. Complete blood count 
3. WBC count may be low inspite of the presence of SBP due to 
Hypersplenism
57
. 
4. Urine analysis and urine culture-asymptomatic bacteriuria is an 
independent risk factor
14
. 
5. Liver function tests-Total and direct bilirubin, liver enzymes-
AST, ALT, SAP, GGT, Total protein and albumin, globulin
54
. 
6. Cefotaxime 2g every 12 hr for 7 days  is the common empiric 
antibiotic. Second ascitic tap done 48 hrs after start of therapy 
and there should be a 30% decrease in cell count. Otherwise 
change the antibiotic
3
. 
 
TUBERCULOUS PERITONITIS 
Extrapulmonary disease Abdominal tuberculosis is the sixthmost 
frequent site
49
.  
PeritonealTB occurs in three types: 
1. Fibrotic type 
2. Encysted (loculated) type 
27 
 
3. Wet type with ascites 
ASCITIC FLUID EXAMINATION 
Macroscopically it  is straw coloured and an exudates (protein 
>3g/L). The total cell count is 500-2000 cells/mm3 with predominant 
lymphocyte (70%). Lymphocytosis of ascitic fluid means they account 
for >30% of total AF cell count
39.
 
In some PMNs are abundant(>250/mm3) early in the disease and 
this can lead to misdiagnosis as SBP
2,39,45.
 
The SAAG has a gradient of <1.1g/dl. The adenosine deaminase 
(ADA) of >33U/L has a sensitivity of 98% and specificity of 100% in 
non-cirrhotic patients
4
. The yield of tubercle bacilli on smear and culture 
is low and large amounts of fluid(about 1L) has to be used for 
centrifuging and the deposit is inoculated on LJ medium. The time taken 
for growth is usually 6-8 weeks
2,29,45.
 
CAUSES OF LOW GRADIENT (SAAG <1.1g/dl) ASCITES
14
 
 TB-AF LDH (<250 U/ml) and glucose level lower 
 Pancreatic ascites 
 Malignancy induced ascites-AF LDH and glucose level higher 
 Biliary ascites 
 Renal ascites  
SELECTIVE INTESTINAL DECONTAMINATION (SID)
23,36,37
 
Norfloxacin is recommended : 
Poor intestinal absorption and rapidly diffuse into ascitic fluid. 
28 
 
Preserves anaerobes and prevents gut colonization by pathogenic 
bacteria. 
Strong activity against gram negative bacteria. 
Has fewer side effects.  
Should be started in
23
: 
Patients with gastrointestinal bleeding ,Norfloxacin 400 mg BD × 7days 
(SHORT TERM). 
AF protein level <1.5g/dl 
Patients who have recovered from previous SBP episode. Newer 
quinolones are preferred since apart from eliminating gram negative 
bacteria,decrease bacterial adhesion to mucosa, and they also stimulate 
bactericidal capacity of PMNs. 
 
Patients who survive an episode of SBP have 41 to 71% chance 
of relapse in the coming 13 months. Hence, long term administration of 
quinolones is advocated for these patients tillsymptoms and signs of 
ascites, transplantation or death. But this approach selects quinolone 
resistant GNB and trend towards infection caused by GPC. For patients 
on quinolone prophylaxis who develop anSBP episode, third generation 
cephalosporins are the bestoption
42
. 
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MATERIALS AND METHODS 
 
STUDY TYPE 
Cross - Sectional Study. 
 
STUDY PLACE 
This study was done in Department of Medical gastroenterology, 
StanleyMedical College in association with the Department of 
Microbiology, Government Stanley hospital, Chennai. 
 
STUDY PERIOD 
November 2012 to JANUARY 2014. 
 
STUDY POPULATION 
During this period ascitic fluid from 422 cases of cirrhosis 
attending the Department ofMedical Gastroenterology, Govt. Stanley 
Hospital were examined forAscitic fluid Infections (AFIs). 
 
Among the 422 DCLD patients, 141 were outpatients and 281 
were inpatients. Among the 141 outpatients, 117 were men and 24 were 
women. Among the 281 inpatients,253 were men and 28 were women. 
 
INCLUSION CRITERIA 
 All inpatients with Decompensated Liver Disease (DCLD), 
beforethe first dose of antibiotic administration. 
 All outpatients with recent onset undiagnosed ascites and  
Non repetitive out patients undergoing therapeutic paracentesis. 
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EXCLUSION CRITERIA 
1. Patients who were on antibiotics in the previous two weeks. 
2. Patients with secondary causes of peritonitis like gut perforation. 
 
ETHICAL CONSIDERATION 
Ethical with  research clearance was obtained from the Ethical 
Committee  Stanley Medical College. Written consent done before 
enrolment. 
 
STATISTICAL DATA 
Statistical data obtained with SPSS Software (Statistical Package 
for Social Sciences) version 20. Univariate analysis was doneusing 
Pearson Chi-Square Test and Fisher’s Exact Test. 
SAMPLE COLLECTION
61
 
PREFERRED SITE FOR PARACENTESIS 
Left lower quadrant was taken with two finger breadths cephalad 
and two finger breadths medial to the anterior superior iliac spine  
(RUNYON’S SPOT)3,  where the abdominal wall is  thinner with larger 
pool of fluid. Right lower quadrant was not the choice since  
appendicectomy scar/dilated caecum are present. 
 
The Inferior epigastric arteries and midline (collaterals) were 
Escaped. Visible collaterals were also escaped. 
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POSITION OF THE PATIENT 
The head end of the bed elevated . Patients with  large volume of 
ascites and thin abdominal wall were “tapped”  in this supine position. 
Patients with less amount of fluid were placed in the lateral decubitus 
position and tapped from left lower quadrant. 
 
NEEDLE OF CHOICE  
Standard metal 1.5 inch,22 gauge needle is used, obese 
Individuals with thick abdominal wall  use longer needle of 3.5 inch 
length . 
 
DISINFECTION OF SKIN 
6
 
 As per Universal precautions gloves  that are sterile were worn 
for the procedure. The skin to be punctured is rubbed using 60% ethanol 
in a circle approximately 4.5cm in diameter and allowed to air dry. 
Starting at the center of the circle, 2% povidone iodine was applied, 
until the entire circle was saturated with iodine and allowed to dry for 
one minute. 
 
TECHNIQUE OF PARACENTESIS 
Under aseptic precautions the disinfected area was injected with 
local anaesthetic, punctured with 22 gauge needle using “Z tract” 
technique. The skin was displaced 2cm downward with one gloved hand 
and the needle was introduced. Needle was introduced through the 
abdominal wall gently. The syringe with the needle was aspirated  
during insertion.When the needle was  released, the skin came back to 
its ground zero position. This helped  the needle pathway to be sealed 
32 
 
and post-procedural leak was avoided. About 50 ml of ascitic fluid was 
withdrawn using syringe. 
 
 
 
 
STRIP TESTING: 
 
The fluid will be checked with a test tube containing the strip MISSION 
ASCITIC FLUID ANALYSIS REAGENT STRIPS 10 U. 
The Strip test detects leukocyte esterasein azurophilic granules. A 
positive value usually shows bacterial presence. 
The leukocyte esterase / NITRITE TEST test is helpful and we must not 
depend on this test to detect infection in ascitic fluid
.
 
Strip test shows the how esterase catalyses the hydrolysis of 
indolecarboxylic acid. The indoxyl combines to diazonium to form a 
violet azole.
[21]
The esterase requires 5 minutes.  
33 
 
 
 
As per the criterias for ascitic fluid testing, strip introduced in to  the 
fluid, followed by 120 seconds the change in the colour was matched 
with the  chart in the container. 
 
The stick is noted as either –ve or  +ve. 
 
SBP diagnosed if dipstick turns blue or violet in colour. 
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LERS STRIP – NO COLOUR       STRIP – COLOUR 
CHANGE   LERS          CHANGE TO PURPLE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strip test color light blue/RED [grade 2: >125 polymorphonuclear 
leucocytes (PMNL)/ μL] or it turned purple/VIOLET (grade 3: >500 
PMNL/μL). 
 
MACROSCOPIC APPEARANCE 
 
Colour and appearance of the fluid was noted-whether crystal 
clear, transparent or slightly yellow, cloudy yellow, bloody, opaque and 
chylous, dark brown. 
 
TRANSPORTNG THE SAMPLES 
 
15 ml of fluid each was inoculated into 40 ml of Brain Heart 
35 
 
Infusion (BHI) broth and 40 ml of Thioglycollate broth at the 
bedside respectively. The BHI and the thioglycollate broth bottles were 
immediately transported to the laboratory and incubated at 36°c.Another 
4ml was collected in a sterile screw capped test tube and sent to the 
microbiology laboratory . 
 
PROCESSING SAMPLES 
 
When the test tube was received in the microbiology laboratory, 
conventionally, centrifugation speed was 3000 revolutions/10 minutes 
and centrifuged sample was inoculated into BHI broth in the laboratory , 
followed up and processed along with the BHI broths inoculated at the 
bedside
15
. 
 
MICROSCOPIC EXAMINATION 
 
From the sediment direct gram stain, acid fast stain was performed. 
 
BACTERIAL CULTURE 
 
A part of the sediment was lysed with Triton X-at room 
temperature, kept 5 minutes and inoculated into Blood agar, Mac 
Conkey agar incubated aerobically at 37 °c for 48 hrs, Chocolate agar 
which incubated at 37 °c in 5% CO2 for 48 hrs, Brain heart infusion 
agar was incubated for 48 hrs. 
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The broth bottles were followedfor 7 days with aerobic and 
anaerobic subculturing at 24, 48 and 168 hrs. Additionally, subculture 
from bedside BHI broth onto 2% Tween 80 BAP was done
11
. 
 
CONVENTIONAL BHI VS BEDSIDE BHI 
 
 
 
IDENTIFYING ISOLATES 
The preliminary tests-motility, catalase, oxidase Gramstain, were 
performed on all isolates and based on the results further identification 
of the isolates were done by standard microbiological tests. 
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ANTIMICROBIAL SUSCEPTIBILITY 
 
The Isolatessubjected to antimicrobial susceptibility testing by 
Kirby-Bauer disc diffusion method. The panel of antibiotics that were 
used with zone diameters used for interpretation is given in annexure 
(Appendix). 
 
Mueller-Hinton agar (MHA) plate is inoculated with 0.5 
McFarland standard of the isolate to get a lawn culture. Using sterile 
forceps, the antibiotic discs were placed over the agar surface, incubated 
at 37°C in ambient air for 16 to 18 hrs. The results were interpreted as 
per Clinical Laboratory Standards Institute Guidelines (CLSI Guidelines 
2012). 
 
The Escherichia coli ATCC 25922, Staphylococcus aureus 
ATCC 25923 and Pseudomonas aeruginosa ATCC 27853 were used as 
quality control strains. The isolates were also tested for Methicillin 
resistance by Cefoxitin disc diffusion method, for ESBL production by 
Phenotypic Confirmatory Test and Carbapenamase production by 
Modified Hodge Test. (CLSI Guidelines 2012). 
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YELLOW PIGMENTED PSEUDOMONAS 
 
 
CEFOXITIN DISC DIFFUSION METHOD 
 
0.5 McFarland standard of the test isolate inoculated as lawn 
culture onto Mueller Hinton agar. Cefoxitin disc (30 μg) was applied 
and incubated overnight at 35oC for 16-18 hrs. Zone size 21 mm 
indicates MRSA and Zone size of � 24 mm indicates MRS. 
 
CEFOXITIN DISC DIFFUSION METHOD SHOWING MRSA 
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PHENOTYPIC CONFIRMATORY TEST 
 
0.5 McFarland standard of the test isolate inoculated as lawn  
culture onto Mueller Hinton agar. Tested by combined disc diffusion 
method using Ceftazidime (30μg) and Ceftazidime-clavulanic acid 
(30/10μg) and incubated overnight at 37°C for 16-18 hrs. ESBL 
production was seen when there is 5 mm in zone diameter for the 
combined disc than when ceftazidime disc was tested alone. 
 
MODIFIED HODGE TEST 
 
1:10 diluted 0.5 McFarland standard of ATCC Escherichia coli 
(25922) inoculated as lawn culture onto Mueller Hinton agar.10μg of 
Ertapenem/Meropenem disc was placed in the centre.3-5 colonies of the 
test isolate was inoculated in straight line out from the edge of the 
disc.The plate was incubated overnight at 37oC for 16-20 hrs. If there 
was, enhanced growth of ATCC Escherichia coli around the streak line 
of test isolate, the isolate was positive for carbapenemase production. 
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CARBAPENAMASE PRODUCTION – MODIFIED HODGE 
TEST 
 
 
FUNGAL AND MYCOBACTERIAL CULTURE 
 
Sabouraud’s dextrose agar was inoculated and incubated at 25°C 
for 10 days and examined daily for growth , Lowenstein Jensen Medium 
was inoculated and incubated at 37°C for 8 weeks examined twice 
weekly for growth respectively (in clinically relavent cases)11. 
 
MOLECULAR METHOD 
 
About 2ml of ascitic fluid was aliquoted and stored at -70°C for 
PCR – amplification of 16S rRNA gene to test for the presence of 
bacterial DNA in Culture Negative Neutrocytic Ascites 
(CNNA).Randomly selected Culture Negative Non-Neutrocytic Ascites 
(CNNNA) were used as controls. 
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ASCITIC FLUID - CELL COUNT 
About 4 ml of ascitic fluid was placed in a tube containing the 
anticoagulant EDTA (ethylenediaminetetraacetic acid) for cell count 
(both total and differential). To another 5ml of freshly tapped ascitic 
fluid, 
 
Leucocyte Esterase Reagent Strip (LERS) / NITRITE reagent 
strip test was dipped and immediately removed and its colour compared 
with the colour chart. 
 
PMN COUNT/μl COLOUR SCALE 
 
GRADE PMNCOUNT/µl COLOUR SCALE 
0 >15 NoChange(NC) 
1 >70 Lightyellow(Y) 
2 >125 Lightblue(B) 
3 >500 Purple(P) 
 
The results obtained from using the LERS/nitrite reagent strip test  was 
compared with the PMN count obtained from the laboratory. 
 
ASCITIC FLUID-BIOCHEMISTRY 
 
About 5 ml of ascitic fluid was placed in a tube and sent for 
biochemistry to estimate Glucose, Total protein, albumin (routine), 
amylase and lactate dehyrogenase ( in clinically relevant cases). 
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FOLLOW UP 
 
Repeat paracentesis was done after 48 hours in culture positive 
and CNNA patients to check for 30% decrease in PMN Count from the 
baseline which signifies resolving infection. 
 
STEPS FOR DNA EXTRACTION 
 
DNA extraction was done using Purefast bacterial Genomic DNA  
minispin prep kit. 
 
1. 200 μl of sample was added to 1.5 ml centrifugetube and centrifuge at 
12000 rpm for 5 min. 
 
2. The supernatant was discarded and 400 μl of lysis buffer was 
added to the pellet in the centrifuge tube and mixed well. 
3. 20 μl of Proteinase K was added to the centrifuge tube and mixed 
well. 
 
4. The centrifuge tubes were incubated at 56°c for 15 min. 
 
5. 200 μl of Isopropanol was  instilled and kept in  Normal temperature 
for the duration of five minutes. 
 
6.  Entire sample INTRODUCED to purefast and centrifuged 12,000 
rpm for one  min. 
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7. The flow of the sample residue was removed and spin sample 
keptinto the collection tube. 
 
8. 500 μl of Wash Buffer-I was added to the purefast spin column and 
centrifuged at 12,000 rpm for 1 min. 
 
9. The flow-through was discarded and the spin column was placed into 
the same collection tube. 
 
10. 500 μl of Wash Buffer-II was added to the purefast spin column and 
centrifuged at 12,000 rpm for 1 min. 
 
11. The flow-through was discarded and the spin column was placed 
into the same collection tube. 
 
12. Empty spin - the empty spin column with collection tube was 
centrifuged for additional 1 min. 
 
13. The spin column was transferred into a fresh 1.5 ml centrifuge 
tube. 
 
14. 50 μl of pre-warmed Elution buffer (56°c) was added to the centre of 
the spin column and incubated for 2 min at room temperature. 
 
15. The spin column was centrifuged at 12,000 rpm for 1 min and the 
column was then discarded. 
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16. Eluted DNA was present in the centrifuge tube and stored at -20 °c 
for later analysis. 
 
POLYMERASE CHAIN REACTION 
 
Before use all the reagents were thawed completely, mixed and 
centrifuged briefly. 
 
MASTER MIX 
 
dNTP mix 10 mM - 0.5 μl 
 
10x Taq buffer - 3 μl 
 
Taq polymerase enzyme - 0.4 μl 
 
10x red dye - 2 μl 
 
Nuclease free water - 14.1 μl 
 
Total - 20 μl 
 
DETECTION MIX 
 
 
COMPONENTS 
 
 
TEST SAMPLE 
PCR Mastermix 20µl 
Universal bacterial 16Sr RNA primermix 5µl 
Purified DNA sample 5µl 
Total reaction volume 30µl 
 
 
Negative control: 
Five μl of water is added in the place of purified DNA. 
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Positive control 
5 μl of positive control (ATCC Escherichia coli 25922) was added 
in the place of purified DNA. 
 
The PCR vials are centrifuged briefly before placing into thermal 
cycler. 
 
AMPLIFICATION PROTOCOL 
 
STEPS TIME TEMPERATURE CYCLES 
Initialdenaturation 4min 95°C 1cycle 
Denaturation 30sec 95°C 
 
 
 
35cycles 
Annealing 30sec 55°C 
Extension 30sec 72°C 
Finalextension 5min 72°C 1cycle 
 
 
ANALYSIS BY GEL ELECTROPHORESIS 
 
Preparation of agarose gel 
 
2% agarose gel was prepared by adding 2 gms agarose powder to 
100ml of electrophoresis buffer, then heated in a microwave oven for 2 
min, mixed well until the agarose was uniformly dissolved.After 
coolingto about 60°C 5 μl ethidium bromide was added to 100 ml of the 
gel tofacilitate visualization of DNA after electrophoresis. Ethidium 
bromide being a mutagen was handled with caution. 
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A well-former template (COMB) was placed across the end of 
the casting tray and the solution was then poured into the casting tray 
which acted as a mold and allowed to solidify. 
 
Electrophoresis (TAE-Tris Acetic acid-EDTA) buffer was poured 
into the electrophoresis tank.After the gel hardened enough, the gel was 
mounted on the electrophoresis tank so that the gel was completely 
immersed. The comb was then carefully removed.  
 
Gel electrophoresis 10 μl of each sample, negative and positive 
controls were loadedinto the respective wells using a micropipette. 10 μl 
of 100 base pairDNA ladder was also loaded into the respective well 
using amicropipette. 
 
Electrical leads were connected. The buffer served as conductor 
of electricity and also controlled the pH. Constant voltage of 50-100 V 
was applied for the gel to run until the ethidium bromide dye had 
migrated ¾ the length of the gel. The negatively charged DNA if 
amplified by PCR migrated from cathode to anode. 
 
The PCR products after the gel electrophoresis were observed 
under UV transilluminator. Amplicons of size 250-500 bp were 
consistent with bacterial DNA amplification. 
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PCR - AGAROSE GEL ELECTROPHORESIS 
 
 
 
UV TRANSILLUMINATOR SHOWING 16S  
rRNA GENE AMPLIFICATION 
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OBSERVATION AND RESULTS 
 
Ascitic fluid was tapped from 422 Decompensated Liver Disease 
(DCLD) patients (141 Outpatients and 281 Inpatients) under aseptic 
precautions. Acid fast stain ,Direct gram stain, were performed  in the 
centrifuged deposit of the samples. 
 
Bacterial and fungal culture is done for the ascitic fluid samples 
and the isolates are identified by standard microbiological tests. 
Antimicrobial susceptibility testing is done for the significant isolates 
according to CLSI Guidelines 2012. 
 
Culture for Tuberculosis is done only in  clinically relevant cases. 
PCR for the detection of  bacterial DNA is performed in the ascitic fluid 
of 20 CNNA (Culture Negative Neutrocytic Ascites) samples and 20 
selected randomly  CNNNA (Culture Negative Non-Neutrocytic 
Ascites) samples. 
 
Univariate analysis of the data was done by Pearson Chi-Square 
Test and Fisher’s Exact Test. The p values less than 0.01 were 
considered as highly stastiscally significant (p <0.01).The p values less 
than 0.05 were considered as stastistically significant (p <0.05) and  
Study results  are presented as follows: 
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TABLE 1: DISTRIBUTION OF AGE IN  DCLD PATIENTS 
(n=422). 
 
 
 
Age in 
Years 
 
Outpatients (n=141) Inpatients  (n=281) 
Male Female Male Female 
n=117 % n=24 % n=253 % n=28 % 
11-20 - 0 2 1.4 4 1.4 4 1.4 
21-30 10 7.1 3    0 18 6.4 2 0.7 
31-40 14 10 3 2.9 37 12.9 2 0.7 
41-50 41 28.8 4   4.3 113 40 6 2.1 
51-60 51 35.7 12   8.6 57 20 12 4.3 
61-70 1 0 - 0 27 9.3 2 0.7 
71-80 2 1.4 - 0 - 0 - 0 
TOTAL 117 83 24 17 253 90 28 10 
141 281 
422 
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TABLE 1:DISTRIBUTION OF AGE IN  DCLD PATIENTS 
(n=422) 
 
Most of the DCLD patients are in the age group of 50-61 yrs, 
then followed by the age group of 40-51 yrs.The mean age was  46.33 
yrs and the median age was 47yrs. Many of them  are males. 
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TABLE 2:ETIOLOGY AND SEX DISTRIBUTIONPATTERN OF 
DCLD PATIENTS:(n=422) 
 
 
ETIOLOGY Out patients (141) Inpatients (281) 
MALE FEMALE MALE FEMALE 
n=117 % n=24 % n=253 % n=28 % 
Alcohol 96 65.7 - 0 155 55.1 1 0.3 
HBV 6 4.2 2 1.4 31 11.0 1 0.3 
HCV 2 1.4 2 1.4 12 4.2 1 0.3 
Cryptogenic 4 2.8 20 14.1 8 2.8 19 6.7 
Alcohol+HBV 4 2.9 - 0 16 5.6 - - 
Alcohol+HCV 1 0.7 - - 9 3.2 - - 
Alcohol+HBV+HCV 1 0.7 - - 2 0.7 - - 
Alcohol+Other 
Causes 
3 2.1 - 0 18 12.7 - - 
HBV+ Other causes - -  - 2  - - 
TOTAL 117  24  253  14  
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TABLE 2 
ETIOLOGY  AND  DISTRIBUTION OF  SEX PATTERNS OF 
DCLD PATIENTS:(N=422). 
Alcoholic LiverDisease leading to cirrhosis is the frequent cause 
of ascites among men in outpatient (66.7%) and inpatient 
(54.1%)category whereas,Cryptogenic cirrhosis is frequent cause among 
women in both the categories with 13.1% in outpatient and 8.7% in in 
patient. 
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TABLE 3: SIGNIFICANT CLINICAL FEATURES IN 
CIRRHOTIC 
PATIENTS AND IN PATIENTS  PRESENTING WITH AFIS: (N 
=158) 
 
SIGNS & SYMPTOMS Outpatients Inpatients 
(141) AFIs (n=34) 281 AFIs (n=117) 
Abdominal Pain(AP) 4(3%)  2(5.8%) 14(5%)  4(3.3%) 
UGI Bleeding (UGB) - - 50(19.2%) 35(24%) 
Diarrhoea (D) - - 21(7.1%) 4(3.3%) 
Hepatic Encephalopathy (HE) - - 26(9.3%) 10(8%) 
Fever (F) 6(4.2%) 6(17.6%) 48(17.1%) 34(27.4%) 
Asymptomatic(A) 131(93%) 26(76.6%) 78(28%) 6(4.8%) 
AP+UGB+F - - 2(0.7%) 2(1.6%) 
AP+F - - 8(3%) 4(3.3%) 
UGB+F - - 4(1.4%) 4(3.3%) 
UGB+HE - - 6(2.1%) 6(4.8%) 
UGB+HE+F - - 4(1.4%) 4(3.3%) 
HE+F - - 16(5.7%) 16(12.9%) 
TOTAL 141 34 140 117 
422 
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AFIs-Ascitic Fluid Infections. 
 
Most of the outpatients are asymptomatic (94%). Among the 
symptomatic inpatients Upper Gastrointestinal bleeding, is the major 
cause.Fever was the major symptom among inpatients with 
AFIs.(25.4%). 
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TABLE 4:LABORATORY PARAMETERS INCIRRHOTIC 
PATIENTS: (n=422) 
 
Laboratory Parameters Outpatients 
(n=141) 
Inpatients 
(n=281) 
Total 
(n=422) 
Leukocyte count >11,000/mm
3 
2 48 50(12%) 
≤11,000/mm3 138 232 370(88%) 
Platelet count <98,000/mm
3 
10 66 76(18%) 
≥98,000/mm3 130 214 344(82%) 
Serum bilirubin <2.5 mg/dl 108 106 214(51%) 
≥2.5 mg/dl 32           174 206(49%) 
Serum albumin ≤ 3.5 g/dl 116 230 346(82.4%) 
>3.5 g/dl 24 50 74(17.6%) 
Serum 
Creatinine 
≥2.5 mg/dl 2 8 10(2.4%) 
1.5-2.4 mg/dl 2 16 18(4.3%) 
<1.5 mg/dl 136 256 392(93.3%) 
        BUN 
BUN  
LESS THAN 
25 
26 79 105(24.8%) 
MORE THAN 
25 
116 203 319(75.5%) 
  LESS THAN 
130 
35 125 260(61.6%) 
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SODIUM MORE THAN 
130 
107 157 264(62.5%) 
 
 
POTASSIUM 
LESS THAN 
4.5  
121 205 326(77.2%) 
MORE THAN 
4.5 
21 76 97(22.9%) 
SAAG ratio     ≤1.1 g/dl 23 41 64(15.1%) 
>1.1 g/dl 121 240 361(85.5%) 
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TABLE 4 LABORATORY PARAMETERS AMONG DCLD 
PATIENTS: 
 
Leukocytosis was seen in only 13% of the total patient 
population. Creatinine levels (>1.5 mg/dl) suggestive of HRS 
(Hepato Renal Syndrome) was seen in 28 patients. Majority of our 
patients had (83.2%) High SAAG ascites. 
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TABLE 5: COMPARISON OF BLOOD NEUTROPHIL 
COUNTVSASCITIC FLUID  IN PATIENTS WITH AFIS: 
 
Ascitic fluid 
PMN count 
AFIs No. of isolates Leukocytosis (>11,000)  with 
Neutrophils  >60% 
≥250/mm3 SBP 113(74.8%) 27 
<250/mm
3
 MNB 51(31.6%) 3 
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The ascitic fluid neutrophil count was elevated (>250/mm3) in 
113 (69.4%) of AFIs among which only 22 had elevated peripheral 
blood neutrophil count. There was no correlation between both and this 
observation was highly statistically significant. 
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TABLE 6: CULTURE POSITIVES IN CIRRHOTIC  
PATIENTS 
AND RISK FACTORS FOR DEVELOPING ASCITIC FLUID 
INFECTIONS (AFIS)  (n=158) 
 
 
SERUM INDICES CULTURE 
NEGATIVES 
CULTURE  
POSITIVES 
 
SIGNIFICANCE 
Bilirubin level ≥ 2.5 mg/dl 
(206) 
112 94(59.5%) P value-0.0227 
< 2.5 mg/dl 
(214) 
           150 64(40.5%) 
Albumin ≤ 3.5 g/dl 
(372) 
226 146(92.4%) P value-0.2624 
> 3.5 g/dl 
(48) 
36 12 (7.6%) 
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The prevalence of Ascitic Fluid Infections (AFIs) in DCLD 
Patients having  raised serum bilirubin (>2.5 mg/dl) and lowered 
albumin<3.5 g) were 58.5%and 91.4%. 
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TABLE 7: CULTURE POSITIVES AMONG CIRRHOTICS  
PATIENTS 
WITH  UGI BLEEDING / HEPATO RENALSYNDROME (n=422) 
 
CLINICAL STATUS TOTAL 
(n=422) 
CULTURE 
POSITIVES 
SIGNIFICANCE 
H/O  UGI Bleeding Present 70 48 (68.6%) p = 0.0001 
Absent 350 110(31.4%) 
HRS-I Creatinine 
≥2.5 mg/dl 
10 8(80%) p = 0.0097 
HRS-II Creatinine 
1.5-2.4 
mg/dl 
18 12(66.9%) 
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The prevalence of AFIs in DCLD patients with UGIbleeding, HRS-I and 
HRS II were 67.6%, 80.1% and 66.8%. 
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TABLE 8:MELD AND CTP SCORE AMONG DCLD PATIENTS 
WITH ASCITIC FLUID INFECTIONS (n=158) 
Score Total Culture positives (n=151) 
Op (n=141) Ip (n=281) Op  (n=34) Ip  (n=124) Total 
CTP 
Score 
(7-9) Class B 100 (71.4%) 92 (32.8%) 24 36 60 
(38%) 
(10-15) Class C 40 (28.6%) 188 (67.2%) 10 88 98 
(62%) 
MELD 
Score 
Low(<15) 110 (78.6%) 130 (46.5%) 26 54 80 
(50.2%) 
High(≥15) 30 (21.4%) 150 (53.5%) 8 70 78 
(49.8%) 
Ip-Inpatients,Op-Outpatients. 
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CTP*-CHILD TURCOTTE PUGH SCORE: Most of the 
outpatients belonged to Class B(72.4%) while most of the inpatients 
belonged to Class C (68.2%). The prevalence of AFIs in DCLD patients 
belonging to CTP Class B was 37% and Class C was 60%. (p=0.0878) 
 
MELD* - MODEL FOR END- STAGE LIVER DISEASE (MELD) 
SCORE: Majority of the outpatients had low score and inpatients 52.5% 
is the  high score (>15) and 45.5% had low score (<15).The AFIs is of 
equal prevalence in DCLD patients with high ( 49.7%) and low (50.3%) 
MELD scores. (p=0.1518) 
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TABLE 9: ASCITIC FLUID INFECTIONS (AFIS) IN 
CIRRHOTICS  OF 
VARIED ETIOLOGIES. 
 
SAAG ETIOLOGICAL FACTORS CULTURE POSITIVES 
GPC GNB  Candida 
Low  
≤1.1 g/dl 
(62) 
Alcohol 6 4 2 
Alcohol/HBV - 2 - 
Alcohol/Malignancy - 2 - 
Post Whipple’s (Hypoalbuminemia) - 2 - 
High 
>1.1 g/dl 
(358) 
Alcohol 30 60 - 
Alcohol/HBV - 8 - 
Alcohol/HCV - 2 2 
Alcohol/HBV/HCV - 2 - 
Cryptogenic 12 8 - 
Budd-Chiari Syndrome - 4 - 
Cholestatic jaundice - 4 - 
Wilson’s Disease - 2 - 
Non Alcoholic Fatty Liver Disease - 2 - 
Non Cirrhotic Portal Fibrosis 2 - - 
HBV/SOL Rt.lobe of Liver(?HCC) - 2 - 
TOTAL 50 108 4 
 
HCC-Hepatocellular Carcinoma  SOL-Space Occupying Lesion. 
This table reveals that AFIs are present in 38 cases of DCLD of 
other etiologies apart from cirrhosis. 
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TABLE 10: MICROBIAL PROFILE  ISOLATED AMONG 
OUTPATIENTS AND INPATIENTS WITH DCLD 
 
PATIENT CATEGORY CULTURE 
POSITIVES 
GPC GNB Candida M.TB 
OUTPATIEN
TS 
(141) 
Males(116) 24 18 6 - - 
Females(24) 10 6 4 - - 
TOTAL 34(24%) 24(75%) 10(25%)   
INPATIENTS 
(281) 
Males(252) 112 22 86 4 2 
Females(48) 12 4 8 - - 
TOTAL 124(44.3%) 26(21%) 94(75.8%) 4(3.2%) 2 
SIGNIFICANCE p = 0.005 p = 0.0003  
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AFIs are more prevalent among inpatients (43.3%) than 
outpatients (23%) (p=0.005). In DCLD outpatients, majority (74%) of 
AFIs were mainly due to Gram positive organisms, whereas in DCLD 
inpatients majority (74.8%) of AFIs were due to gram negatives. (p = 
0.0003) In addition to 158 culture positives in AFIs ,there 2 cases of 
Tuberculous Peritonitis. The Tubercle bacilli was absent in AFB Smear 
but LJ medium culture yielded growth in 5 weeks. Faster results with 
sensitivity was obtained by MGIT. 
MGIT-Mycobacterial Growth Indicator Tube. 
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TABLE 11: CLASSIFICATION OF ASCITIC FLUID 
INFECTIONS IN CIRRHOTICS PATIENTS VARIANTS OF 
AFIs 
 
VARIANTS  TOTAL 
 
Culture Positives 
GPC GNB Candida 
Spontaneous bacterial peritonitis 
(SBP) 
108 
(68.4%) 
20 86 2 
Monomicrobial  
non-neutrocytic bacterascites 
(MNB) 
50 
(31.6%) 
30 18 2 
TOTAL 158(100%) 50(31.7%) 104 
(65.8%) 
4(2.5%) 
Culture Negative Neutrocytic 
Ascites 
(CNNA) 
20 - - - 
 
Among the 158 Culture Positive AFIs in DCLD patients based on 
PMN count 108 (68.4%) were categorized as SBP and 50 (31.6%) 
were  
categorized as MNB. Among the isolates GPC was found in 
31.7%, GNB 
in 65.8% and Candida in 2.5% of AFIs respectively .GPC was 
predominant among the MNB category and GNB was predominant 
among the SBP category. (p = 0.0004) 
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TABLE 12: COMPARING DIRECT GRAM STAIN FINDINGS 
WITH CULTURE POSITIVES (n=158) 
 
AFIs DIRECT GRAM STAIN -PMNs ORGANISM Culture 
Positives 
Nil Few 
(<10/HPF) 
Moderate 
(11-40/HPF) 
Plenty 
(>40/HPF) 
+ - 
SBP 
20 
MNB 
30 
30 10 6 4 4 46 GPC (50) 
SBP 
86 
MNB 
18 
18 16 56 14 18 86 GNB 
(104) 
SBP 
2 
MNB 
2 
2 - - 2 2 2 Candida 
(4) 
 
HPF-High Power Field 
 
PMNs were absent in Direct Gram Stain in all cases of MNB. In 
SBP plenty of PMNs were seen in candida infection, followed by GNB 
and GPC. 
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TABLE 13: COMPARING ASCITIC FLUID MACROSCOPY 
WITH DIAGNOSTIC YIELD-CONVENTIONAL VS 
BEDSIDE 
INOCULATION (n=422) 
 
Macroscopy No. Of 
samples 
(n=422) 
Conventional-BHI 
broth 
Triton-x Bedside BHI broth 
+BAP +2% 
Tween80             
BAP 
Clear 378 10 36 112 126 
Slightly 
turbid 
10 4 4 8 8 
Cloudy 14 12 12 12 14 
Chylous 4 2 2 2 2 
Muddy brown 6 4 4 4 4 
Pale coloured 4 2 - 2 2 
Haemorrhagic 4 2 2 2 2 
Total 422 36 (8.6%) 60(14.3%) 142(33.8%) 158 (37.6%) 
SIGNIFICANCE  p=0.0000 p=0.0000 p=0.0000 
 
Cloudy, slightly turbid, chylous, muddy brown, pale and 
haemorrhagic ascitic fluids yielded culture growth even by conventional 
method, but clear ascitic fluid samples yielded more culture positives 
only when bedside inoculation technique was used. Among the 422 
samples NO OBLIGATE ANAEROBES were isolated. 
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TABLE 14: MICROBIAL PROFILE ISOLATED BY EACH 
OF 
THE DIFFERENT CULTURE METHODS 
 
 
Organism Total 
n=151 
(%) 
Conventional-BHI 
broth 
Triton-X Bedside BHI broth 
+BAP +2%  
Tween 80 BAP 
Klebsiella 
pneumoniae 
40(25.3%) 6 26 36 40 
Klebsiella oxytoca 8(5.1%) 8 8 8 8 
Escherichia coli 20(12.7%) 8 10 20 20 
Enterobacter 
aerogenes 
10(6.3%) 2 2 8 10 
Pseudomonas 
aeruginosa 
8(5.1%) 2 2 6 8 
Acinetobacter 
baumanii 
4(2.5%) - - - 4 
Citrobacter freundii 2 (1.3%) - - - 2 
Citrobacter koseri 2(1.3%) - - 2 2 
Pseudomonas luteola 4(2.5%) - - - 4 
Proteus species 4(2.5%) 2 2 4 4 
Serratia marcescens 2(1.3%) - - 2 2 
Staphylococcus 
aureus 
20(12.7%) 2 4 20 20 
CONS 14(8.8%) - 2 14 14 
Enterococcus faecalis 8(5.1%) - - 8 8 
Enterococcus 
faecium 
4(2.5%) 2 2 4 4 
Streptococcus Group 1(1.3%) 2 - 2 1 
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A 
Streptococcus Group 
B 
1(1.3%) - - 2 1 
Candida albicans 2(2.5%) 2 2 4 2 
TOTAL 158(100%) 
 
36 
(22.8%) 
60 
(38%) 
140 
(88.6%) 
158 
(100%) 
SIGNIFICANCE  p=0.000 p=0.000 p=0.000 
 
 
The organisms sequestered within the neutrophils and probably 
liberated by the surfactant action of 2% Tween 80 were Klebsiella 
pneumoniae(2) Enterobacter (1) Citrobacter freundii (1), Pseudomonas 
aeruginosa(1) and Pseudomonas luteola (2) and Acinetobacter 
baumanii(2). 
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TABLE 15:RESULTS OF LEUKOCYTE ESTERASE 
REAGENT STRIP(LERS) TEST COMPARED WITH GOLD 
STANDARD CELL COUNT IN AFIs 
 
AF PMN 
count/mm
3 
No.  Colour change GPC 
(38) 
GNB 
(116) 
Candida 
(4) 
NC Yellow Blue Purple N Y B P N Y B P N Y B P 
0-70 
 
244 244 
(100%
) 
- - - 10 
 
- - - 6 - - - - - - - 
71-125 
 
28 20 8 
(28.5%) 
-  8 4 - - 4 2 - - - - - - 
126-500 
 
140 24 18 86 
(61.4%) 
12 6 4 2 4 1
4 
4 62 4 4 - - - 
>500 
 
8 - - - 8 
(100%
) 
- - - - - - - 8 - - - - 
TOTAL 420 288 26 86 20 38 116 4 
 
 
NC-No change, Y-Yellow, B-Blue, P-Purple 
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TABLE 15: RESULTS OF LEUKOCYTE ESTERASE REAGENT 
STRIP(LERS) TEST COMPARED  WITH GOLD STANDARD 
CELL COUNT IN  ASCITIC FLUID INFECTIONS: 
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TABLE 16 RESULTS OF LEUKOCYTE ESTERASE REAGENT 
STRIP(LERS) TEST COMPARED  WITH GROWTH OF GRAM 
POSITIVE COCCI AND GRAM NEGATIVE BACILLI  IN 
ASCITIC FLUID INFECTIONS: 
AF PMN 
count/mm
3 
No of 
patients 
Blue colour 
change 
Purple colour 
change 
Blue 
GPC 
Blue 
GNB 
Purple 
GNB 
126-500 
 
140 86 
 
 2 
(2.3%) 
62 
(72.09%) 
 
>500 
 
8 - 8 
 
- - 8 
 
 
The strip accurately identified PMN count in the lowest range (0- 
70) and the highest range (>500) with appropriate colour change, that is, 
with 100% accuracy .For the PMN counts in the ranges (71-125) and 
(126-500) the colour change was appropriate in 28.5% and 61.4% 
respectively. 
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TABLE 17:RESULTS OF  NITRITE DIPSTICK COMPARED  
WITH GOLD STANDARD CELL COUNT IN AFIs: 
AF PMN 
count/mm
3 
No.  Colour change GPC 
(38) 
GNB 
(116) 
Candida 
(4) 
white pink red violet W P R V W P R V N Y B P 
0-70 
 
244 244 
(100%) 
- - - 10 - - - 6 - - - - - - - 
71-125 
 
28 20 8 
(28.5%) 
-  8 4 - - 4 2 - - - - - - 
126-500 
 
140 24 18 86 
61.4% 
 
12 6 4 2 4 14 4 62 4 4 - - - 
>500 
 
8 - - - 8 
(100%) 
 
- - - - - - - 8 - - - - 
TOTAL 420 288 26 86 20 38 116 4 
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TABLE 17:RESULTS OF  NITRITE REAGENT STRIP TEST 
COMPARED  WITH GOLD STANDARD CELL COUNT IN AFIs: 
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TABLE 18 RESULTS OF NITRITE REAGENT  REAGENT 
STRIP TEST COMPARED  WITH GROWTH OF GRAM 
POSITIVE COCCI AND GRAM NEGATIVE BACILLI  IN 
ASCITIC FLUID INFECTIONS: 
AF PMN 
count/mm
3 
No of 
patients 
RED colour 
change 
VIOLET 
colour change 
RED 
GPC 
RED 
GNB 
VIOLET 
GNB 
126-500 
 
140 86 
 
 2 
(2.3%) 
62 
(72.09%) 
 
>500 
 
8 - 8 
 
- - 8 
 
The strip accurately identified PMN count in the lowest range (0- 
70) and the highest range (>500) with appropriate colour change, that is, 
with 100% accuracy .For the PMN counts in the ranges (71-125) and 
(126-500) the colour change was appropriate in 28.5% and 61.4% 
respectively. 
 
 
 
 
 
 
 
80 
 
TABLE 19: ASCITIC FLUID ALBUMIN AND SUGAR LEVELS 
AMONG DCLD PATIENTS WITH ASCITIC FLUID 
INFECTIONS(n=158) 
 
ASCITIC FLUID 
PARAMETERS 
GPC GNB Candida Culture 
Positives 
SIGNIFICANCE 
ALBUMIN ≤1.5 g/dl 
(272) 
42 92 2 136(86%) p=0.0001 
>1.5 g/dl 
(148) 
8 12 2 22(14%) 
TOTAL 
PROTEIN 
≤1.5 g/dl 
(180) 
22 60 2 84(14%) p=0.0217 
>1.5 g/dl 
(240) 
28 44 2 74(47%) 
SUGAR <50 mg% 
(106) 
16 84 2 102(64.6%) p=0.0002 
50-100 mg% 
(118) 
24 14 0 38(24.1%) 
>100 mg% 
(196) 
10 6 2 18(11%) 
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TABLE 19:  ASCITIC FLUID ALBUMIN AND SUGAR LEVELS 
AMONG DCLD PATIENTS WITH ASCITIC FLUID 
INFECTIONS(n=158): 
 
 
 
The prevalence  due to AFIs among  DCLD associated risk 
factors like decreased ascitic fluid albumin (<1.5g/dl) and total protein 
(<1.5g/dl) and low ascitic fluid sugar levels (<100 mg%) was found to 
be 82%, 55% and (64.7%+24.2%) 86.8% respectively. 
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TABLE 20: THE ANTIMICROBIAL SUSCEPTIBILITY 
PATTERN OFINPATIENTS WITH AFIS 
 
 
ORGANISM 
 
 
ANTIMICROBIAL AGENT 
 
ESBL/
MBL 
Cefo or 
cefta 
(30µg) 
Nor 
(10µg) 
Cip 
(5µg) 
Gen 
(10µg) 
Ak 
(30µg) 
Amc or PTZ 
(20/10µg) 
or 
(100/10µg) 
Imi/ 
Mero 
(10µg) 
 
GNB S R S R S R S R S R S R S R 
Kleb 
pneumoniae 
(17) 
24 10 14      
 
20 28 
 
6 
 
32 2 32 1 28  6 10 - 10 
Kleb oxytoca 
(2) 
0 4 0 4 0 4 2 2 4 0 4 - 4 - 4 
Escherichia 
coli (10) 
10 10 6 14 8 12 12 8 20 0 14 6 10 - 10 
Enterobacter 
(5) 
6 4 2 8 8 2 10 0 10 0 - 4 - 4 
Pseudo 
aeruginosa(4) 
4 4 2 6 6 2 8 0 8 0 8 0 4 - 4 
Pseudo 
luteola(2) 
2 2 2 2 4 0 4 0 4 0 4 0 2 - 2 
Acinetobacter  
(2) 
0 4 0 4 2 2 4 0 4 0 0 4 2 2 2/2 
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Citro freundii 
(1) 
2 0 2 0 2 0 2 0 2 0 - - - - 
Citro koseri (1) 0 2 0 2 2 0 2 0 2 0 - 2 - 2 
Proteus 
mirabilis (1) 
2 0 2 0 2 0 2 0 2 0 2 0 - - - 
Proteus 
penneri (1) 
2 0 2 0 2 0 2 0 2 0 2 0 - - - 
Serratia (1) 2 0 2 0 2 0 2 0 2 0           - 
 
- 0 
STAPH 
SPECIES 
(18) 
Pen-G 
(10 U) 
Cefox 
(30µg) 
Nor 
(10µg) 
Cip 
(5 µg) 
Gen 
(10µg) 
Ak 
(30 µg) 
Doxy 
(30 µg) 
MRS 
S R S R S R S R S R S R S R  
Staph 
aureus(5) 
4 6 2 8 2 8 8 2 8 2 10 0 6 4 8 
CONS (4) 12 4 8 8 4 12 6 2 6 2 8 0 8 0 4 
ENTEROCOC
CUS 
(8) 
Pen-G 
(10 U) 
Doxy 
(30 µg) 
HLG 
(120µg) 
HLS 
(300µg) 
Van 
(30 µg) 
Linezolid 
(30 µg) 
Quinuprist
in 
(15 µg) 
VRE/
HLA
R 
Entero. 
Faecalis (4) 
S R S R S R S R S R S R S R  
4 4 8 0 8 0 4 0 4 0 - - - - - 
Entero.faecium  
(4) 
4 4 8 0 4 4 2 2 2 2 2 - 2 - 2/2 
 
The prevalence of MRS, ESBL,VRE, HLAR and MBL among 
pathogens responsible for AFIs among inpatients were 66.7%, 41.4%, 
27%,26% and 2.2% respectively. 
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TABLE 21: THE ANTIMICROBIAL SUSCEPTIBILITY OF 
OUTPATIENTS WITH AFIs 
 
ORGANISM 
 
ANTIMICROBIAL AGENT  
ESBL/
MBL 
Cefo or 
cefta 
(30µg) 
Nor 
(10µg) 
Cip 
(5µg) 
Gen 
(10µg) 
Ak 
(30µg) 
Amc or PTZ 
(20/10µg) 
or 
(100/10µg) 
Imi/ 
Mero 
(10µg) 
GNB S R S R S R S R S R S R S R 
Kleb 
pneumoniae 
(6) 
6 0 6     
 
0 6 
 
0 
 
6 0 6 0 6  0 - - - 
Kleb oxytoca 
(4) 
2 2 4 0 2 2 4 0 4 0 4 - 2 - 2 
STAPH 
SPECIES(16
) 
Pen-G 
(10 U) 
Cefox 
(30µg) 
Nor 
(10µg) 
Cip 
(5 µg) 
Gen 
(10µg) 
Ak 
(30 µg) 
Doxy 
(30 µg) 
MRS 
S R S R S R S R S R S R S R 2 
Staph aureus 
(10) 
8 2 8 2 6 4 8 2 8 2 10 0 10 0 
CONS (6) 6 0 6 0 2 4 4 2 4 2 6 0 6 0 - 
ENTEROCO
CCUS(4)  
Pen-G 
(10 U) 
Doxy 
(30 µg) 
HLG 
(120µg) 
HLS 
(300µg) 
Van 
(30 µg) 
Linezolid 
(30 µg) 
Quinupri
stin 
(15 µg) 
VRE/H
LAR 
Entero. 
faecalis 
(4) 
S R S R S R S R S R S R S R - 
4 0 4 0 4 0 4 0 4 0 - - - - 
 
The prevalence of MRS and ESBL among pathogens responsible 
for AFIs among outpatients were 12.6% and 21% respectively. 
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TABLE 22:MICROBIAL PROFILE OF DCLD INPATIENTS 
WITH HEPATIC ENCEPHALOPATHY(n=52) 
 
         HEPATIC 
ENCEPHALOPATHY 
(52) 
CULTURE 
POSITIVES 
(36) 
ORGANISMS 
(n=36) 
UREASE POSITIVE 
(30) 
UREASE 
NEGATIVE(6) 
IP  MALES 
(48) 
32 
 
26 Kleb-18 6 
Proteus-2 
Pseudo-2 
Acineto-2 
Citro-2 
IP FEMALES 
(4) 
4 
 
4 Kleb-2 - 
Acineto-2 
SIGNIFICANCE p=0.0078 
 
Among the 52 DCLD patients with Hepatic Encephalopathy, 
Ascitic fluid yielded culture positives in 37 samples and among 
them UREASE producing organisms were 31 (83.4%)  
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TABLE 23: COMPARING  CLINICAL DATA AND 
LABORATORY DATA IN BACTEREMIC CIRRHOTICS 
INPATIENTS WITH AFIS (N=28) 
 
CLINICAL DATA   GPC 
  (n=4) 
  GNB 
 (n=20) 
CANDIDA 
     (n=4) 
AGE 30-40 - 4 2 
40-50 - 10 - 
50-60 2 6 2 
60-70 2 - - 
SEX MALE 4 18 4 
FEMALE - 2 - 
GI BLEEDING YES 4 14 2 
NO - 6 2 
PLATELET COUNT <98,000 2 14 2 
≥98,000 2 6 2 
PT Elevated  (>15 sec) 4 14 0 
Normal    (≤15 sec) - 6 4 
INR Normal    (≤ 1.2) - 6 2 
Elevated  (>1.3) 4 14 2 
LEUKOCYTOSIS 
(≥11,000) 
PRESENT - 8 0 
ABSENT 4 12 4 
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TOTAL BILIRUBIN >2.5 mg/dl 2 8 4 
≤ 2.5 mg/dl 2 12 0 
CREATININE <1.5 4 12 4 
≥1.5 - 8 0 
CTP CLASS B - 6 2 
CLASS C 4 14 2 
MELD <15 - 2 4 
≥15 4 18 0 
OUTCOME SURVIVAL 2 12 2 
DEATH 1 8 2 
 
Among DCLD inpatients who had bacteremia along with 
AFIs,majority  were males(92.8%),had history of  gastrointestinal 
bleeding (71.3%),low platelet count (64.2%),elevated prothrombin 
time(64.1%) and INR (71.3%).In 50% of patients serum bilirubin was 
raised.Majority belonged to CTP Class C (71.3%) and had high MELD 
score (78.4%). About 12 (42.8%)  patients with bacteremic AFIs  
succumbed to death.Gram negatives were isolated in 20 (71.5%),gram 
positives in 4 and candida in 4 (14.4%) cases respectively. 
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TABLE 24: COMPARISON OF PCR DETECTION OF 16S rRNA 
IN  20 CNNA AND 20 CNNNA SAMPLES: 
 
AF 
16S rRNA 
CNNA 
(PMN Count ≥ 250/mm3) 
 
(n=20) 
CNNNA 
(PMN Count < 250/mm
3
) 
 
(n=20) 
Present 6 2 
Absent 14 18 
SIGNIFICANCE p=0.5820 
 
 
Bacterial 16S rRNA gene was detected in 31% of the CNNA  
samples by PCR which were empirically treated with cefotaxime had 
Dminished PMN count and favourable outcome. 
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TABLE 25: COMPARING  POST TREATMENT PMN 
DECREASE  IN INPATIENTS WITH AFIs (n=124) 
 
AFIs GPC GNB Candida Total 
26 94 4 124 
Post Rx PMN 
decrease 
(<25% from baseline) 
20 82 2 104 
 
Among the 124 AFIs among inpatients,the PMN count decreased 
(to <27% from baseline) in 114 cases after treatment with appropriate 
drug intravenously . The AFIs in which PMN count failed to decrease  
were due to GNB(12), GPC (6) and candida(2) all of which culminated 
in death. The mortality rate was 16.3%.  
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TABLE 26:GROWTH  WITH TREATMENT PROFILE,POST Rx 
PMN COUNT OF INPATIENTS (n=20) WITH AFIs 
SUCCUMBING TO  DEATH (n=20): 
AF PMN GROWTH Rx POST Rx PMN 
COUNT 
CAUSE OF DEATH 
200 Staph aureus (MRSA) Vanco1gm iv 12
th
hrly 200 UGI Bleed/HE 
100 CONS (MRS)  Vanco 1gm     iv 
12
th
hrly 
100 Health care associated 
pneumonia 
300 Escherichia coli (ESBL) Mero 1gm iv 12 hrly 500 UGIBleed/ Hypovolemic                    
shock 
260 Pseudo aeruginosa 
(ESBL) 
Imipenem  500 mg iv 
thrice daiy 
300 UGIBleed/ Hypovolemic shock 
100 Enterococcus faecium 
(VRE) 
vancomycin 1gm iv 
12
th
hrly, doxy 100 
mg twice daily 
100 HE/Aspiration 
pneumonia/Sepsis 
150 Candida albicans Fluconazole 200mg 
iv once daily 
400 HE/UGI Bleed 
20 Pseudomonas 
species(ESBL) 
Pip- tazo 4.5 gm iv 8 
hrly 
200 Cellulitis leg/Sepsis 
50 Pseudomonas 
species(ESBL) 
Pip- tazo 4.5 gm iv 8 
hrly 
400 UGI Bleed/HE 
260 Acinetobacter (MBL) Imipenem  500 mg iv 
thrice daily  
300 Hepatorenal Syndrome 
250 Acinetobacter (ESBL) Imipenem  500 mg iv 
thrice daily 
200 Hepatorenal Syndrome 
AF PMN GROWTH Rx POST Rx PMN 
COUNT 
CAUSE OF DEATH 
200 Staph aureus (MRSA) Vanco1gm iv 12
th
hrly 200 UGI Bleed/HE 
100 CONS (MRS)  Vanco 1gm     iv 
12
th
hrly 
100 Health care associated 
pneumonia 
300 Escherichia coli (ESBL) Mero 1gm iv 12 hrly 500 UGIBleed/ Hypovolemic                    
shock 
91 
 
260 Pseudo aeruginosa 
(ESBL) 
Imipenem  500 mg iv 
thrice daiy 
300 UGIBleed/ Hypovolemic shock 
100 Enterococcus faecium 
(VRE) 
vancomycin 1gm iv 
12
th
hrly, doxy 100 
mg twice daily 
100 HE/Aspiration 
pneumonia/Sepsis 
150 Candida albicans Fluconazole 200mg 
iv once daily 
400 HE/UGI Bleed 
20 Pseudomonas 
species(ESBL) 
Pip- tazo 4.5 gm iv 8 
hrly 
200 Cellulitis leg/Sepsis 
50 Pseudomonas 
species(ESBL) 
Pip- tazo 4.5 gm iv 8 
hrly 
400 UGI Bleed/HE 
260 Acinetobacter (MBL) Imipenem  500 mg iv 
thrice daily  
300 Hepatorenal Syndrome 
250 Acinetobacter (ESBL) Imipenem  500 mg iv 
thrice daily 
200 Hepatorenal Syndrome 
 
 
All the AFIs which culminated in death of the patients, the post 
treatment PMN count failed to decrease and all were due to 
organismsexhibiting special resistance mechanisms. The other co-
morbid factors are listed in the table. 
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DISCUSSION 
 
Ascitic Fluid Infections (AFIs) is  the most frequent infection in 
Cirrhotic patients with prevalence ranging from 9% to 31%. SBP is 
associated with mortality ranging from 21-41%.  
 
Thorough knowledge of the pathogenesis, risk factors, and the 
resistance pattern ,organism profile commonly prevalent among them in 
our setup is necessary to bring down the mortality associated with AFIs. 
 
Leukocyte esterase found in the PMNs andreleased upon lysis of 
PMNs during inflammatory cascade. The strip when placed inside a test 
tube of fresh ascitic fluid at the bedside and kept for 90 seconds. The 
esterase present in the PMNs act on the estersubstrate and releases 3-
hydroxy-5-phenyl-pyrrole.this changes the color. The calorimetric scale 
reference chart is available for direct optical comparison on the sides of 
the container. 
Accuracy Nochange Yellow Blue Purple 
Sensitivity 100% 28.5% 61.4% 100% 
Specificity 75% 95.4% 100% 97% 
 
Our results from the LERS strip showed good correlation with 
Bruce A Runyon
10
 mentions sensitivity of strip to be 96%,specificity to 
be 89% and negative predictive value 99%. Balagopal et a
l7
reported 
sensitivity of 93% and specificity of 98%. 
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Nitrites also help in diagnosing ascitic fluid infections as it is reduced by 
the baterias.The sensitivity, specificity, positive and negative predictive 
are as follows12%, 9%, 41%, and 78%. 
But our study showed below the different values of this nitrite 
reagent test. 
ACCURACY WHITE PINK RED VIOLET 
SENSITIVITY 100% 28.5% 61.4% 100% 
SPECIFICITY         75% 95.4% 100% 97% 
 
The reactive strips detect nitrite by using the Greiss reaction to 
produce a pink azo dye.Our results from the nitrite reagent strip showed 
good correlation withBruce A Runyon
10
 mentions sensitivity of strip to 
be 96%,specificity to be 89% and negative predictive value 99%. 
 
Butani et al
20
 used leukocyte esterase reagent strip/nitrite strip 
test to diagnose SBP in 136 specimens by using grade 2 as a cut-off 
scale, and found the sensitivity, specificity, PPV and NPV of the 
leukocyte esterase reagent strip/nitrite strip test  as 83%, 99%, 91%, and 
98% respectively. In study done by Vanbiervliet et al, nine of 72 
patients included were diagnosed with SBP, another leukocyte esterase 
reagentstrip/nitrite reagent strip test  was positive in all cases with 100% 
sensitivity and specificity.14 Sapey et al found sensitivity, specificity, 
PPV, NPV of leukocyte esterase reagent strip as 64.7%, 99.6%, 91.7%, 
and 97.4% respectively.
19
 Kim et al revealed 50% sensitivity, 100% 
specificity, 100% PPV and 87% NPV of the leukocyte esterase reagent 
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strip/nitrite reagent strip test in his study
.18
 Thevenot et al found 89% 
sensitivity, 100% specificity, 100% PPV and 99% NPV.
17
 
 
Our team evaluated the prevalence of AFIs among 422 Cirrhotics 
patients withComparison to patient population – outpatients (Op) vs 
inpatients (Ip), various etiologies, risk factors. Our team also evaluated 
microbial profile of isolates from Op and Ip population, their 
antimicrobial susceptibility and screened for special resistance 
mechanisms exhibited by them. Our team evaluated if bedside 
inoculation of ascitic fluid into blood culture bottles combined with 
newer culture methods yielded significant diagnostic yield withrespect 
to conventional method of laboratory inoculation. 
 
Most of the patients in our study population are of age group 50- 
61years, followed by 40-51years. The mean age group in the 
studypopulation is 45.43 years and the median age 47 years. There was a 
good correlation with the median age in studies by Grunhage et al
5
 
who70 had median age of 50 years, Dodammani et al
22 
with similar most 
common age group, Zahidullah et al
71 
who had population with 
medianage 52.5 years. Majority were males as expected. (82% of 
outpatients and91% of inpatients). 
 
The most commonest cause of cirrhosis in the male patients was 
ALCOHOLIC CIRRHOSIS (66.7% among outpatients and 58.4% 
among inpatients) which correlated well with study conducted by 
Pazhanivel
51
,Grunhage et al
8
where alcoholic cirrhosis was 57.5% and 
64.7%. Cryptogenic cirrhosis was the most frequent cause in cirrhosis 
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among female inpatients which correlated with the study by Grunhage et 
al
8
. 
 
The majority of outpatients with AFIs were asymptomatic 
(78.6%).The predominant symptoms among inpatients with AFIs 
werefever (28.4%) which correlated well with the studies conducted 
byCaruntu
28
(32%) and as stated by McHutchison (68%)
48
.  
 
In our by 5.8% of inpatients with AFIs were asymptomatic the 
importance of these groupwas also as highlighted by Schiff (upto30%)
25
. 
 
Leukocytosis was present in only 14% of our study population. 
Studies conducted by Todd et al
66
 also states that there will only be 
subtleelevation probably due to hypersplenism as stated by Kerr41(11%) 
andKoulaouzidis
42
 in their studies. 
 
The ascitic fluid neutrophil count is increased (>250/mm3) in 108 
(67.4%) patients (categorized as SBP) of AFIs in which only 23 patients 
had elevated peripheral blood neutrophil count. This proved that 
asciticfluid neutrophil count had no correlation with peripheral blood 
neutrophil count. This observation in our study proved that the good 
correlation with the study conducted by Angeloni et al
62
. The PMNs 
reaches theperitoneal sac with response to specific stimulus and where 
there are localongoing pathogenesis guided by chemotactic factors 
(Mainor et al
46
). In this study raised serum total bilirubin (>2.5 mg/dl) 
was associated with AFIs in 58.5% and this was stastistically 
significant(p=0.0229) .The importance this parameter as independent 
risk factor hasbeen ascertained by various studies conducted by 
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Angeloni et al
62
, Riberiet al
55 
and Jiannis Anastasiou
34
 who confirmed 
the importance in their 
multivariate analysis. 
 
Low serum albumin level (<3.5 g/dl) is present  with AFIs in 
91.4% of our study. Serum albumin level also forms a  good variable in 
CTP score. The significance of this parameter as risk factor is published 
in article published by Erica Horinek
24
and but we see no Significant 
stasistical association (p=0.2624) in our study. 
 
The second most symptom among inpatients is UGI bleeding 
(23%). The prevalence of AFIs among cirrhotic patients with UGI 
bleeding was 69.6% in our study which showed good correlation with 
the study done by Yang et al
 70
 who states 66% association. Thalimer et 
al
65
and Goulis et al
30
 also reports 66% prevalence 50% respectively. 
Thisassociation was highly stastistically significant (p=0.0002) 
 
AFIs were prevalent in 88% of patients with HRS-I and 65.7 % 
of patients with HRS-II in our study. Raised serum creatinine (>1.1 
mg/dl)was found as an independent predictor of mortality in study 
conducted byLubna Kamani
44 
and Anastasiou et al
34
 in their multivariate 
analysis. This association was of high stastistical significance 
(p=0.0098) . 
 
In our study the cause of death was concluded as HRS in 4 of the 
patients.Most of the outpatients belonged to Class B (73.4%) ,inpatients 
belonged to Class C (68.2%) in our study. AFIs prevalence in DCLD 
patients belonging to CTP Class C (63%). This correlates well the 
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review article by Cesar Alaniz
20 
who states 72% SBP occurs in CTP 
Class C.Analysis by Anastasiou et al34 and Such et al37 also stated this. 
In our study no patients belonged to Class A and nosignificant 
difference (p=0.0879) among prevalence of AFIs between Class B and 
C patients. 
 
In our study inpatients 52.5% with high score (>15) and 48.5% 
withlow score (<15). The AFIs was of equal prevalence in DCLD 
patientswith high ( 48.8%)and low (51.2%) MELD scores 
(p=0.1529).The AFI was associated with acase of Whipple’s procedure, 
a case of malignant ascites, and a case each of Wilson’s Disease, 
NonAlcoholic Fatty Liver Disease, Non Cirrhotic Portal Fibrosis, 
HBV+SOLRt.lobe of Liver (?HCC) supported by Isner
32 
who also 
reported aninteresting case of gastric CA metastasis associated with SBP 
and 2 cases of Cholestatic jaundice and Budd-Chiari Syndrome. Person 
et al. havereported two patients with Wilson's disease who developed 
SBP
52
.  
 
It was pointed out by Todd
47 
in his review article that SBP 
occurrence in other causes of cirrhosis is rare. Hepatocellular carcinoma 
may result in anincrease in the risk of developing SBP in cirrhotic 
patients by furtherimpairing antimicrobial defense mechanisms (Goulis 
et al
30
). 
 
The (p value=0.4271) had  no change , so we conclude that 
patientswith  any etiology to  be screened for AFI by ascitic fluid 
culture.We found that the prevalence of AFIs was 25% among 
outpatients most of them are asymptomatic and in  inpatients is 44.3% 
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and that difference ishighly statistically significant (p=0.006).This 
correlated well with Todd A.Sheer66 who had prevalence of 30% and 
3.5% respectively. Also had good correlation with other studies by 
Bunchorntavakul et al
21
, . Studies by Vargese et al
69
, Evans et al
45
, 
Pazhanivel
51
, Riberio et al
55
 AFIs among outpatients were found to be 
3.7% ,3.5% , 2.5% and 11% respectively.Lubna Kamani
44
,carnutu et al
28
 
showed 25-31%, 24% and 25% prevalence among inpatients 
respectively.  
 
In our study 76% of AFIs in outpatients are  due to Gram positive 
organisms and 76.8% of AFIs are inpatients, due to gram negatives and 
this difference was highly stastistically significant(p=0.005)and this had 
good correlation with Riberio et al55 where 80% was due to GNB and 
as stated by Rimola et al5(65%).This is due to the quinolone prophylaxis 
and emergence of AFIs by gram positives among outpatients and drug 
resistant GNB emergence, leading to complications needing 
hospitalisation. 
 
There was two case of Tuberculous Peritonitis. There was no 
lymphocytic predominance as supported by Faisal M.Sanai
26
. But LJ 
medium culture yielded growth in 4 weeks in ourstudy, done after 
centrifugation of one litre of ascitic fluid as supportedby Mimidis et al
49
, 
Ali Uzunkoy
2 
(6 weeks). The Tubercle bacilli was absent in AFB Smear 
as supported by Angeline et al
4
, Ali Uzunkoy
2
,Kashyap et al
53
, Mimidis 
et al
49
(3%), BruceA.Runyon (AFB SMEAR-0% SENSITIVITY) who 
said that thesensitivity of AFB smear is very low and usually AFB 
smear isnegative. 
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Mimidis et al
49
found positive culture in 22% of cases. Rapid results (14 
days) with sensitivity (sensitive to rifampicin and INH) were obtained 
by MGIT (Tsi-ShuHuang et al
67 
) 
 
In our study,  on ascitic fluid PMN count. 108 (66.4%) were 
categorized as SBP and 50 (32w.6%) were categorized as MNB, 
Dodammani et al
22
had 89% SBP and 14% MNB among culture 
positiveAFIs. GPC was predominant among the MNB category and 
GNB waspredominant among the SBP category and this was highly 
statisticallysignificant (p = 0.0004). This showed good correlation with 
Riberio etal
55
, Dodammani et al
22 
who found 81% and 63.5% of AFIs 
due to GNBamong SBP.20 of our patients had CNNA. 
 
In our study, Direct gram stain (DGS)  organisms were seen only 
in 24 samples which are macroscopically cloudy/slightly turbid. Atleast 
10
5 
organisms/ml in the sample need to be present to be seen by DGS. 
The median ascitic concentration of bacteria inAFIs was1 organism/mL. 
Expecting to see organism in DGS of ascitic fluid was as bad as 
searching bacteria from Gram stain of blood(sleisenger
61
), also 
supported by Cesar Alaniz
20
-poor diagnostic yield. 
 
In our study, conventional method found around 23.8%,Triton-X 
Found 39%, bedside inoculation Found 88.6%, and bedside inoculation 
combined with 2% Tween-80 BAP Found 100% of culturepositives. 
Each of the other three methods Found more culture positiveswith 
respect to conventional laboratory inoculation and there was 
highstatistical significance for all the three methods (p=0.000) 
incomparison with conventional method. This was due to 
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lowconcentration of bacteria (1-2 organisms/ml) , delay in transport 
which lead to continuous phagocytosis and the recovery was 
low,(Runyon
15
).  
 
So small variations in cultures processing has hugeimpact on the 
results like bedside inoculation which diluted the effects ofantibodies, 
complement,previously used antibiotics as also concluded bySumittra 
Charoenhirunyingyos
63
. 
 
Klebsiella, the common isolate (30.2%) followed by Escherichia 
coli(12.7%)among GNB. Cesar et al
20 
in his study stated that 46% of 
AFIs were due to Escherichia coli and Klebsiella accounted for 9%. 
Caruntu et al
28
observed 60% were due to Escherichia coli and Klebsiella 
put together. 
 
Among GPC the common isolate was Staphylococcus aureus 
(12.9% of AFIs). Overall GNB isolated was 77% and GPC was 22% and 
candida 4%. 
 
In our study, the 9 organisms additionally recovered using of 2% 
Tween 80 BAP were Klebsiella pneumoniae(2) Enterobacter(1) 
Citrobacter freundii(1), Pseudomonas aeruginosa(1) and 
Pseudomonasluteola(2) and Acinetobacter baumanii(2) among which 3 
were ESBLproducers and one carbapenemase producer. 
 
In our study, obligate anaerobes were not isolated from any of the 
samples. This showed good correlation with study by Cesar et al
20 
whoreported 0%. This was in accordance that the anaerobes 
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thoughpredominant in bowel flora are unable to translocate and unable 
toproliferate in ascitic fluid with high oxygen content. (Carnutu et 
al
28
and Cesar et al
20
 and Todd A.Sheer
66
). 
 
In our study among patients with AFIs, glucose level 
was<50mg% in 67.6% and in the range 50-100mg% in 
27.1%respectively. This observation was of high statistical 
significance(p=0.0001). Normally, the concentration of glucose in 
ascitic fluid is parallels that of seum. In bacterial infection of ascitic 
fluid, the glucose drops down and sometimes even upto as stated by 
(Sleisenger
61
). 
 
AF albumin levels <1.5g/dl  with highest incidence of AFIs as 
pointed by Kashani A et al
40
, Anastasiou et al
34
. In our study,prevalence 
of AFIs in with this AF albumin <1.5g/dl was 88% and AF total protein  
1.5g/dl was 52%. The former association wasstatistically highly 
significant(p=0.0001), while the latter associationwas statistically 
significant ( p=0.0217). This showed good correlation with Schiff 
25
(24%). 
  
The prevalence of MRS, MBL ,ESBL, HLAR ,VRE, and  among 
pathogens responsible for AFIs among inpatients were 
67.6%,41.4%,28%,29% and 2.8% respectively. 
 
In GNB norfloxacin resistance was 62.7% and 59.5% among 
staph species. In  GNB Ciprofloxacin resistance was 27 % and 23.8% 
among staph species. The prevalence of MRS and ESBL among 
pathogens responsible for AFIs among outpatients were 12.9% 
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(p=0.0499) and 21% (p=0.6375) respectively. Among GNB 
norfloxacinresistance was absent in isolates from outpatients and 59% 
amongStaph species. 
 
Norfloxacin resistance was widespread in isolates from inpatients 
than outpatients and this was highly statistically significant (p=0.003), 
while isolates from both group of patients showed decresed resistance to 
ciprofloxacin (p=0.373). 
 
We did an interesting observation in our study:  Among the 52 
patients with Hepatic Encephalopathy,AFIs were positive for 36 patients 
and among them UREASE producing organisms were 30 (84.3%) .This 
observation was highly statistically significant (p=0.0078). 
 
Among the inpatients with AFIs with bacteremia as evidenced by 
positive blood cultures is seen in 28 (22.5%). Bert et al12 study showed 
24.5%. Gram negatives were isolated in 20 (71.4%), gram positives in 2 
and candida in 4 (14.3%) cases respectively in our study. Anastasiou et 
al
34
 observed candidal sepsis in 15% of AFIs. About 12 (42.9%) patients 
with bacteremic AFIs succumbed to death (2 GPC+8 GNB+2 Candida). 
Shizuma et al
60
 had mentioned in her articlethat bacteremic AFIs were 
common in patients with UGI bleeding andin our study we found 
positive association 20 patients (72.4%) had h/oUG Bleeding. 12 
(43.9%) patients with bacteremic AFIs succumbed to death. 
 
 
 
103 
 
Bactrial DNA (byPCR amplification of 16S rRNA) was present 
in three ascitic fluid samples from 20 patients with CNNA compared 
with 20 CNNNA samples. In our study, the culturenegativity in these 
patients could be explained by continuous ongoingopsonisation process 
so that only remains of bacterial wall or innercomponents only will be 
found in ascitic fluid that could not be revivedby culture (Such et 
al
38
).CNNA is the expected 20% failure rate toisolate the organism 
(Hecser et al
31
).All the CNNA patients were routinely treated with 
favourable outcome (p=0.5820).  
 
Mostafa et al
47 
reported Sughira et al study were 11.4% of CNNA 
patients had bacterial DNA. This was consistent with the fact that 
BACTERIALTRANSLOCATION ACROSS gut that is important in 
pathogenesis ofAFIs. 
 
Among the 124 AFIs among inpatients, the PMN count decreased 
(to <25% from baseline) in 108 cases after treatment with appropriate 
drugintravenously . The AFIs in which PMN count failed to decrease 
were due to GNB(12), GPC (6) and candida(2) all of which culminated 
in death. 
 
The mortality rate was 16.2% in our study. Lubna 
Kamani
44
reported 30% mortality .We put forth that the use of bedside 
inoculation into blood culture bottles combined with newer culture 
detection methods employing non-ionic surfactants decreased the turn 
around time which was responsible for bringing down the mortality rate. 
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All the AFIs which culminated in death of the patients, the post 
treatment PMN count failed to decrease and all were due to organisms 
exhibiting special resistance mechanisms like ESBL, 
Carbapenemaseproduction and GPCs Methicillin Resistant Staph AND 
Vancomycinresistant enterococci were seen. This showed good 
correlation asobserved by Kyoung-Ho Song
43
. The other co-morbid 
factors present among patients with AFIs that culminated in death were 
UGI bleeding(6), UGI bleeding AND HE (4) HRS(4)HE(4),Health care 
associated pneumonia(2). 
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SUMMARY 
 
In the cross sectional study conducted among 422 DCLD 
patientsstated that LER strip test and nitrite reagent strip test had better 
accuracy  with increased specificity of 96% and sensitivity of 89%,PPV  
94% NPV 98% and accuracy of 100% for SBP. Grade II /IIIcolor had 
better indicators of SBP.These two grades used are 125 and 500 PMNL/ 
mL in comparison to the gold standard for diagnosis of SBP of 250 
PMNL/mL. These two values were useful for identifying SBP.  
 
The LER is according to the esterase activity of granulocytes. 
These cells release leukocyte esterase into the extracelullar milieu reacts 
with an ester releasing 3-hydroxy-5-phenyl-pyrrole which causes a color 
change in the azo dye in the reagent strip. 
 
The strip in our study  accurately identified PMN count in the 
lowest range (0- 70) and the highest range (>500) with appropriate 
colour change, that is, with 100% accuracy .For the PMN counts in the 
ranges (71-125) and (126-500) the colour change was appropriate in 
28.5% and 61.4% respectively. 
 
Results of this study are quite different from otherstudies 
published to date evaluating the use of leukocyte esterase dipstick test in 
the diagnosis of SBP as this study not only detects the SBP bedside but 
also compares the Bed side inoculation of ascitic fluid in culture bottle 
and also identify the organism responsible for the infection and follow 
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up bed side LER strip test with ascitic fluid bed side inoculation 
showing reduction in cellcount after antibiotic therapy. 
 
Vanbiervliet et al  had first studied the use of LER  in Ascitic 
Fluid. They studied using Multistix 8 SG strips,and  
the sensitivity and specificity was 100% .  
The sensitivity for the diagnosis of SBP has ranged between 85% and 
100%, and the specificity between 98% and 100%. 
 
 
Thus,strip test  is accurate,  rapid, easy  and cheaper. Further, it 
should be possible to apply this test to determine the effectiveness of 
antibiotic therapy in patients with SBP by repeating the test, though this 
aspect needs further studies. 
 
Castellote et al
15
 studied the use of Aution sticks (A. Menarini 
Diagnostics, Firenze, Italy) for diagnosis of SBP in cirrhotic patients 
with ascites who underwent abdominal paracentesis at a university 
based hospital, and found that the sensitivity, specificity and PPV are 
89%, 99% and 98%, respectively. The benefit of the Aution stick is the 
precise colorimetric scale that correlates with ≥250 PMN cells/mm3. 
Sarwar et al used Combur 10 urine strip fordiagnosis of SBP and found 
97.7% sensitivity and89.4% specificity with positive predictive value of 
90%, negative predictive value of 97.7%.
27
 
 
The limitations of the strip test include absence of a cut-off 
corresponding to cell count of 250 PMNL/mL in the reagent strip, and 
the possibility of inter-observer variation in matching of color.  
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In the cross sectional study conducted among 422 DCLD patients 
the prevalence of AFIs was 38.6%. The prevalence of AFIs among 
DCLD patients with CIRRHOSIS and Mixed ascites (Cirrhosis plus 
another cause for ascites) was 78%.The prevalence of AFIs among 
DCLD of other etiologies-Cryptogenic causes, Budd-Chiari Syndrome, 
Cholestatic jaundice, Wilson’s Disease, Non Alcoholic Fatty Liver 
Disease, Non Cirrhotic Portal Fibrosis, Hepatocellular carcinoma, Post 
Whipple’s procedure (Hypoalbuminemia) was 28%.So,invariably in 
patients with non-cirrhotic ascites ( because of other etiologies also) we 
recommend ascitic fluid culture be done as admission surveillance tap. 
 
The prevalence of AFIs was 47.3% among inpatients and 28% 
among outpatients with DCLD. Yet the prevalence rate was higher in 
our study compared with other studies. So, we would like to emphasise 
that ascitic fluid culture should be performed in all cases of undiagnosed 
ascites attending the op, and have constant vigilance over patients on 
therapeutic paracentesis. 
 
From the results of our study we conclude that bedside 
inoculation of ascitic fluid into blood culture bottles combined with 
newer culture methods using non-ionic surfactants yielded 77.3% higher 
culture positivity than conventional method. 
 
Overall 75.9% of the AFIs were due to gram negative bacilli, 
23% due to gram positive cocci and 3.3% due to candida. Among the 
inpatients gram negatives were the predominant cause (75.9%) and 
among outpatients gram positives (78%) were the predominant cause of 
AFIs respectively. The prevalence of Methicillin Resistant 
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Staphylococcus (MRS) and Extended Spectrum Beta Lactamase 
producers (ESBL) were 12.6% and 21% among outpatients & 66.6% 
and 40.3% among inpatients respectively. Among inpatients the 
prevalence of VRE , HLAR and carbapenemase producers was 26%, 
26% and 2.4% respectively. 
 
The GNB and GPC resistant to norfloxacin among those isolated 
from outpatients were 0% and 57% respectively. Among the GNB and 
GPC isolated from inpatients the prevalence of norfloxacin resistance 
was 61.4% and 69% respectively. 
 
We would like to put forth that this clone of drug resistant gram 
positives and gram negatives exacerbates the ongoing pathogenesis in 
these patients who are already immunocompromised leading to 
complications that require hospitalisation, risk of future episodes of 
AFIs and other septic complications. 
 
We concluded from the results of our study that combining bed 
side strip testing of ascitic fluid and bedside inoculation into blood 
culture broths with newer techniques decreased the number of ascitic 
fluid samples as being falsely reported sterile and early, specific 
antibiotic therapy was given to the patients. 
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CONCLUSION 
 
In conclusion, our study shows that LER strip test has Excellent 
accuracy for SBP, and it is having high speed, less cost, easy to use, and 
doesn’t require expert hands. Because of its speed, the use of this test 
may help early institution of antibiotic therapy in patients with SBP. 
 
The prevalence of AFIs among DCLD patients with cirrhosis was 
79% and the prevalence among patients with various other etiologies for 
DCLD (like Cryptogenic, Budd Chiari Syndrome, Hepatocellular 
carcinoma etc) was 28%. 
 
The prevalence of AFIs was 26% among outpatients and 44.7% 
among inpatients with DCLD.  
 
Klebsiella was the most common isolate (30.4%), followed by 
Escherichia coli (12.6%) and Staphylococcus aureus (12.8%). Gram 
positive cocci (77%) were the predominant cause of AFIs among 
outpatients and Gram negative bacilli (75.9%) were predominant cause 
of AFIs among inpatients. 
 
The prevalence of Methicillin Resistant Staphylococcus (MRS) 
and Extended Spectrum Beta Lactamase producers (ESBL) were 12.5% 
and 20% among outpatients & 66.5% and 40.4% among inpatients 
respectively.25% of Enterococci isolated among inpatients exhibited 
Vancomycin Resistance (VRE) and High Level Aminoglycoside 
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Resistance (HLAR).The prevalence of carbapenemase production was 
2.1% among isolates from inpatients. 
 
The percentage of resistance to norfloxacin among GNB and 
GPC isolated from outpatients was 0% and 50% & inpatients was 61.7% 
and 67% respectively. 
 
The percentage of resistance to ciprofloxacin among GNB and 
GPC isolated from outpatients was 20% and 25% & inpatients was 
29.8% and 22.2% respectively. 
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APPENDIX 
 
 
 
 
 
 
 
 
 
LERS TEST 
It is normal so find up to 3 (occasionally 5) leukocytes per high 
power field (40X) in a ascitic fluid sample. The strip test for white blood 
cells detects leukocyte esterase, which is present in azurophilic granules 
of monocytes and granulocytes (neutrophilic, eosinophilic and 
basophilic). Bacteria, lymphocytes and epithelial cells from the 
genitourinary tract do not contain esterases. Neutrophil granulocytes are 
the leukocytes most commonly associated with ascitic fluid infections. 
Ascitic fluid test strip 
Leukocytes     
Nitrite     
Urobilinogen    
Protein     
pH    
Haemoglobin     
Specific gravity     
Ketone    
Bilirubin     
Glucose     
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A positive test for leukocyte esterase normally indicates the presence of 
bacteria and a positive nitrite test . 
Theasciticfluid test strip reaction is based on the action of 
leukocyte esterase in catalysing the hydrolysis of an ester of 
indolecarboxylic acid. The indoxyl that is liberated combines with a 
diazonium salt in order to produce a violet coloured azole dye.  
 1) Reaction catalysed by leukocyte esterase  
Indolecarboxylic acid ester → Indoxyl + Acid 
 2) In acid medium  
Indoxyl + Diazonium salt → Violet azole dye 
The esterase reaction needs about 5 minutes to take place. The 
presence of strong oxidising agents or formaldehyde can cause false 
positives. False negative results are associated with elevated 
concentrations of protein (greater than 500 mg/dL), glucose (greater 
than 3 g/dL), oxalic acid and ascorbic acid.  
NITRITES TEST 
The test for nitrites is a rapid screening method for possible 
asymptomatic infections caused by nitrate-reducing bacteria.. The test is 
a rapid screen for possible infections by enteric bacteria 
The reactive strips detect nitrite by using the Greiss reaction in 
which the nitrite reacts in an acid medium with an aromaticamine (para-
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arsanilic acid or sulphanilamide) in order to form a diazonium salt that 
in turn reacts with tetrahydrobenzoquinoline to produce a pink azo dye.  
 1) In an acid medium  
Para-arsanilic acid or sulphanilamide + NO2 → Diazonium 
salt 
 2) In an acid medium  
Diazonium salt + tetrahydrobenzoquinoline → Pink azo 
dye 
 
BRAIN HEART INFUSION BROTH 
 
Sodium citrate 1 gm 
Sodium chloride 4 gm 
Sodium phosphate 5 gm 
Dextrose 10 gm 
Peptone 10 gm 
Brain infusion broth 250 ml 
Heart infusion broth 750 ml 
 
Obtain ox brain and heart. Remove all fat from the heart. Cut into 
small pieces and grind. Add distilled water three times. Keep at 4°C 
overnight. From the brain remove meninges fully and weigh. Add 
distilled water three times. Keep at 4°C overnight. Next morning boil 
the brain and heart separately, for 30 minutes. 
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Then, filter through cotton layer. Mix both infusions and the remaining 
ingredients. Dissolve well and adjust pH of to 7.4 -7.6. Autoclave at 
121°C for 15 min. Filter through filter paper and distribute about 50 ml 
in screw capped bottles .Autoclave once more at 115°C for 10 minutes. 
 
THIOGLYCOLLATE BROTH 
 
Yeast extract, water soluble 5 g 
Casein hydrosylate, pancreatic digest 15g 
Glucose 5.5 g 
L-cystine 0.5 g 
Agar 0.75 g 
Sodium chloride 2.5 g 
Sodium thioglycollate 
(mercaptoacetate) 0.5 g 
Resazurin sodium solution,1 in 1000, 
freshly prepared 1ml 
Water 1 litre 
 
Dissolve the ingredients other than thioglycollate and resazurin 
by steaming at 100°C. Add the thioglycollate and adjust the pH to 7.3.If 
there is a precipitate, heat without boiling and filter hot through 
moistened filter paper. Add the resazurin solution, mix thoroughly, 
distribute and sterilize by autoclaving at 121°c for 15 minutes. Cool at 
once to 25 °c and store in the dark between 20°c and 30°c.If more than 
the upper third is pink in colour, anaerobic conditions may be restored 
once only by steaming at 100°c for a few minutes. 
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BLOOD AGAR 
 
The medium is prepared by adding sterile defibrinated sheep 
blood(5-10%) to sterile nutrient agar that has been melted and cooled to 
50°c.Mix well and pour plates. Any bubbles caused by mixing of the 
blood and the agar can easily be removed bydrawing a Bunsen flame 
quickly across the surface of the medium in the dish. 
 
MAC CONKEY AGAR 
 
Peptone 20g 
Sodium taurocholate 5g 
Agar 20 g 
Neutral red solution, 
2% in 50% ethanol 3.5g 
Lactose, 10 % aqueous solution 100ml 
Dissolve the peptone and taurocholate in the water by heating. Add the 
agar and dissolve it in the steamer or autoclave. If necessary, clear by 
filtration. Adjust the pH 7.5. 
 
2% TWEEN 80 BLOOD AGAR 
 
Constituents-Tween 80 (2%; 20 ml) incorparating Columbia agar 
base (39.0 g; Oxoid), distilled water (910 ml), and sheep blood (7%; 70 
ml) (Difco) was prepared by the following method. The agar was mixed, 
and the Tween 80 was added. The mixture was autoclaved at 121°C for 
15 min and allowed to cool, the blood was added, and the plates were 
poured. Plates were kept at 4°C for up to 4 weeks. 
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CHOCOLATE AGAR(HEATED BLOOD AGAR) 
 
Sterile defibrinated blood 10 ml 
Nutrient agar(melted) 100 ml 
Melt the nutrient agar. When the temperature is about 45 to 50 °C add 
the blood and mix well. After the addition of blood, heat in water bath 
slowly bringing up the temperature to 75°C with constant agitation. 
Heating is continued till the blood changes to chocolate colour. Cool to 
about 50°C and pour plates. 
 
 
BRAIN HEART INFUSION AGAR 
 
Agar granules 1.5 gm 
Brain Heart infusion broth 100 ml 
Dissolve agar and autoclave it at 121°C for 15 min.Cool to about 
50°C and pour plates. 
 
MUELLER- HINTON AGAR 
 
Beef infusion 300 ml 
Casein hydrosylate 17.5 gm 
Starch 1.5 gm 
Agar 10 gm 
Distilled water 1000 ml 
The ingredients were dissolved in one liter of distilled water, mixed 
thoroughly. Heated with frequent agitation and boiled for 1 minute. pH 
adjusted to7.4. Sterilized by autoclaving and poured in plates. 
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SABOURAUD DEXTROSE AGAR 
 
Dextrose 40 gm 
Neopeptone 10 gm 
Agar 20 gm 
Distilled water 1000 ml 
Mix the ingredients in water by heating. Adjust the PH to 
5.6.Sterilize in autoclave at 121°C for 15 min. Cool 100 ml of sterile 
SDA to 50°C.Add 5 mg of Chloramphenicol, dissolved 1ml of 95% 
alcohol and gentamicin. Mix and pour plates. 
 
LOWENSTEIN JENSEN MEDIUM 
 
BUFFERED SALT SOLUTION 
Potassium dihydrogen orthophosphate 28 gm 
Disodium hydrogen orthophosphate 16 gm 
Magnesium sulphate 1.6 gm 
Citric acid 12 gm 
L-Asparagine 40 gm 
Glycerol 80 ml 
Distilled water 4 litres. 
Add and dissolve the ingredients. Dispense in 400 ml amounts and 
autoclave at 110°C for 10 min. 
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COMPLETE MEDIUM 
 
Buffered salt solution 1200 ml 
Whole egg 2000 ml 
1% M alachite green 80 ml 
Scramble the eggs using a mixer and add the other reagents. The 
PH of the medium is 6.95.Dispense in 3.5 ml amounts in thin glass 
universal containers. Inspissate containers horizontally at 85°C for 1 
hour to form a solid slope. 
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KEY TO MASTER CHART 
 
Cr - Seru m Creatinine 
AF - Ascitic Fluid 
AF-TC - A scitic Fluid Total Count 
AF-PMN - Ascitic Fluid Polymorphonuclear leukocyte count 
LERS - Leukocyte Esterase Reagent Strip 
NC - No change 
AF-alb - As citic Fluid albumin 
SAAG - Serum Ascites Albumin Gradient 
Hb - Haemoglobin 
TC - Total white blood cell count 
DC - Differential white blood cell count 
P - Polymorphs 
L – Lymphocytes 
Ab pain - Abdominal pain 
UGI bleeding - Upper Gastrointestinal b leeding 
HE - Hepatic Encephalopathy 
CTP - Child Turcotte Pugh Score 
MELD - Model for End- Stage Liver Disease Score 
Bilirubin(Tot/Dir) - Total and Direct blirubin 
AST/SGOT - Serum aspartate aminotransferase/Serum 
glutamateoxaloacetate transaminase 
ALT/SGPT - Serum alanine aminotransferase/Serum glutamate 
pyruvatetransaminase 
ALP - Serum alkaline phosphatase 
PT - Prothrombin time 
INR - International normalised ratio 
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R - Monocytes, Eosinophils, Basophils 
DGS - Direct gram stain 
Gen - Gentamicin 10 μg 
Ak - Amikacin 30 μg 
Amc - Amoxyclauv 10/30 μg 
PTZ - Piperacillin Tazobactam 10/100 μg 
HLG - High Level Gentamicin 120 μg 
Van/Vanco - Vancomycin 30 μg 
Tetra - Tetracycline 30 μg 
Imi - Imipenem 10 μg 
WM - Wet mount 
Org - Organism 
AFB - Acid Fast Bacilli 
BHI - B rain Heart Infusion broth 
BAP - Blood agar plate 
SDA - Sabouraud’s Dextrose Agar 
Post Rx PMN - Post Treatment Polymorphonuclear leukocyte count 
ND - Not done 
NG - No growth 
ANTIBIOTIC DISCS 
Cefo - Cefotaxime 30 μg 
Cx - Cefoxitin 30 μg 
Cefta - Ceftazidime 30 μg 
Nor - Norfloxacin 5 μg 
Cip - Ciprofloxacin 5 μg 
Pen G - Penicillin G 10 Units 
Mero - Meropenem 10 μg 
MRSA - Methicillin Resistant Staphylococcus aureus 
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MSSA - Methicillin Sensitive Staphylococcus aureus 
ESBL - Extended Spectrum beta Lactamase 
MBL - Metallo beta Lactamase 
VRE - Vancomycin Resistant Enterococci 
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PROFORMA 
 
 
Name: 
Age: 
Sex: 
Occupation: 
Address: 
O.P No./IP No.: 
Micro ID No: 
Complaints: 
Past History 
Personal History: 
Clinical History: 
H/o Previous SBP: 
Treatment History: 
General Examination: 
Systemic Examination: 
Routine investigatory findings: 
Ascitic fluid Analysis: 
�Cell count �SAAG 
�Protein �Amylase 
�Albumin �AFP 
USG Abdomen report: 
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ANTI PLAGIARISM 
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